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The William Beaumont Research Awards are given to three students
for outstanding research accomplishments from work submitted
for publication in Fusion, the student-run research magazine at GW
School of Medicine and Health Sciences.
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GW MEDICAL STUDENT RESEARCH
MEDICAL STUDENT RESEARCH OPPORTUNITIES

A number of competitive scholarship programs are available to assist in funding exceptional projects in health care
and medicine, including diversity targeted fellowships,
the Jean L. Fourcroy M.D. Research Award, Health Services
Scholarships, the Lazarus Family Scholarship Program, and
the WT Gill Fellowship, among others.
In 2020, 22 students won a Gill Summer Research
Fellowship and 65 students received a Health Services
Scholarship, which are internally funded programs that
provide stipend support for medical student research in the
summer.
For a list of SMHS student research funding opportunities,
timelines, and application tips visit the website smhs.gwu.
edu/research/research-workforce/medical-student-research/
medical-student-funding-opportunities.

CHAUDHRY RECEIVES 2020 SPECK AWARD

Sharjeel Chaudhry, MD ’20
The 2020 recipient of the ecipient
of the annual Doris DeFord
Speck, BA ’41, and George
Speck, MD ’41 Endowed Prize for
outstanding accomplishments
in medical student research was
Student Medical Research was
Sharjeel˛Chaudhry,˛MD˛’20. Chaudhry
demonstrated an exceptional
record of research accomplishment
throughout his years at medical
school. Chaudhry also received the
prestigious Sarnoff Cardiovascular
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Fellowship, which supported his
research on the role of coagulation
factor XII in arterial clot formation
at Beth Israel Deaconess Medical
Center under the mentorship of
Robert Flaumenhaft. This work led
to several frst author and co-author
publications, presentations at
national meetings, and supported
the award of an additional $1
million dollars in funding from
Bayer Pharmaceutical.

ALMEIDA RECEIVES
AMERICAN BRAIN
TUMOR ASSOCIATION
FELLOWSHIP
Neil Almeida,
MSIV, earned
a competitive
fellowship from
the American
Brain Tumor
Association,
and the Carolyn
Kuckein student
Neil Almeida, MSIV
fellowship
from the Alpha
Omega Alpha honor society in
support of his research. He also
received a Beaumont Research
Award for outstanding research
accomplishments

METEOR PROGRAM
The Mentored Experience to
Expand Opportunities in Research
(METEOR) program is a competitive fellowship for underrepresented-in-medicine students. For more
information, visit the website smhs.
gwu.edu/academics/md-program/
admissions/METEOR.

Fusion | 2021

Research plans were extensively
disrupted this year due to the
COVID-19 epidemic However, medical
students demonstrated considerable
ingenuity and fexibility in modifying
plans to involve research goals that
could be accomplished remotely In
addition, as shown in this photo of
students participating in collecting
samples for laboratory testing, medical
students were extensively involved in
community outreach and support to
Washington, D C , residents affected by
the epidemic

ASH MINORITY MEDICAL STUDENT AWARD
Guido Pelaez,
MSIII, a
recipient of
a fellowship
from the
METEOR
program,
will have a
chance to
Guido Pelaez, MSIII
build on his
passion for
research after being chosen for the
American Society of Hematology
(ASH) 2020 Minority Medical

Student Award Program. Pelaez
is investigating ways to improve
antibody-directed immunotherapy
in B-cell lymphoproliferative disease
under the supervision of Alejandro
Villagra, PhD, assistant professor
of biochemistry and molecular
medicine at SMHS and a researcher
in the GW Cancer Center, and
Christopher Hourigan, MD, DPhil,
an investogator at the National
Institutes of Health.

WALTER FREEMAN
RESEARCH WINNER
Keirsten Snyder,
MD ’20, won
the 2020
recipient of
the Walter
Freeman
award. The
annual
award is
Keirsten Snyder, MD ’20
given to the
graduating
senior who submits the best scientifc
paper based on original research.

WT GILL FELLOW
Noor Diab, MSII, BS ’19, won
the 2020 WT Gill Fellowship
to continue her research on
the epigenetic regulation of
cancer pathogenesis, under the
mentorship of Katherine Chiappinelli, PhD, assistant professor
of microbiology, immunology,
and tropical medicine This work
was initiated while Diab was an
undergraduate at GW and the
picture (on left) above shows
her in the lab prior to COVID-19
masking precautions

LETTERS
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Beaumont Society President’s Letter
In an effort to
highlight some
of the impressive work undertaken by medica l st udents
at The George
Zachary Falk, MSII
Washington
University
(GW) School of
Med ici ne a nd
Health Sciences
(SMHS), we, the
co-presidents
of the William
H . B e au mont
Zoe Shancer, MSII
Medical
Research Honor
Society, proudly
present the 2021 edition of Fusion.
The ofcial research journal of the
GW SMHS, Fusion is a student-led
publication that aims to circulate
the research achievements of GW
medical students to provide a forum
to communicate their findings and
also to illustrate the broad spectrum of research conducted at GW.
This edition received over 50 submissions for publication, which far
surpasses the previous record high
for a single year, which is a testament to student engagement and a
burgeoning research environment
at our institutions. We believe that
the rich diversity of opportunities in

4

research ofered at GW is refected
in the various disciplines represented
in this edition, which include work in
basic science, clinical medicine, translational research, medical education,
public health, and health policy.
This year especially, we are humbled and inspired by the efforts of
our SMHS colleagues, who not only
navigated the typical challenges in
conducting research but also had to
contend with the COVID-19 pandemic that has so greatly afected us
all. Abstracts were submitted from
students of each of the four MD classes
and several submissions directly investigated the impact of COVID-19 on
clinical practice, which demonstrates
the fexibility and determination of
both the students and their principal
investigators in adapting to the rapidly
evolving research landscape and producing quality work that will beneft
our society.
While we are disappointed that
2020 forced us to miss the in person
interactions of last spring’s Medical
Student Research Day, which was
changed to an on-line format, we
are pleased that Beaumont was able
to adapt and remotely deliver our
workshop talk series for the frst year
class and plan to develop 2021 Medical
Research Day into an interactive
and virtual format. These outlets
are essential to the development and

refnement of research skills for members of all classes and we are delighted
to play a role in this process. It is clear
that in recent years, the trajectory of
student involvement in research has
decidedly increased, which is strong
evidence that GW is committed to
providing opportunities for its students and cementing its reputation as
a university entrenched in investigation and discovery.
We would like to thank our mentors, especially our faculty advisor
David Leitenberg, MD, PhD, associate professor of microbiolog y,
immunology, and tropical medicine at
the GW SMHS, and medical director
of fow cytometry and immunology
at Children’s National Hospital,
and Thomas Kohout, director of
publications at GW SMHS, for their
guidance and assistance with this publication. We would also like to thank
the Fusion co-leaders and editorial
board members (listed in the table of
contents) for their contributions to
this work.
We hope you enjoy reading this
edition of Fusion and that you will
consider contributing to the journal
next year!

Zachary Falk and Zoe Shancer
Co-Presidents, William
H. Beaumont Medical
Research Honor Society

Fusion | 2021

Letter from the Editors
As future clinicians, we have
a responsibility
not only to our
patients but
also in our sign i f ica nt con t r ibut ion s to Alice Chen, MSI
t he a d v a nce ment of science
a nd develop ment of scientific thinking.
Without scientif ic research,
the crucial link
b e t w e e n o u r Isabel Park, MSI
modern knowledge of medicine and the intricacies
of patient care would simply not exist.
Here at the George Washington
University (GW) School of Medicine
and Health Sciences (SMHS), research
plays an everyday role in the lives of
our students as they work to improve
health care in numerous ways, all
while moving one step closer to
solidifying their own careers as future
physician-scientists.
As co-directors of the Fusion
Editorial Board, we are pleased to
present the 2021 edition of Fusion, a
student-run research publication that
highlights the diversity of research
conducted by our very own medical students at GW SMHS. The
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articles presented in this journal
span a wide range of research disciplines, including basic science,
clinical medicine, public health,
among others. As a research journal,
Fusion’s primary goal is to provide an
outlet through which students have
the opportunity to proudly showcase
their research to their peers and the
general GW community. Beyond
that, Fusion aims to fulfll the goals
of the broader William H. Beaumont
Medical Research Honor Society,
which serves as a forum for students
to learn about peer research and
share research experiences with one
another. This year, the top Fusion
abstracts were selected to receive
the prestigious William Beaumont
Research Award and present their
research at GW Medical Student
Research Day held in May. This initiative is designed to further exemplify
the accomplishments of our students
and represent their commitment to
advancing the health care feld in different areas of focus.
The breadth and depth of student research evident in our quality
abstract submissions speaks to the
diverse interests of GW medical students, and we hope readers become
inspired to develop research interests
of their own and join the fourishing
GW SMHS research community in
the near future. We also hope that

this journal initiates more discourse
surrounding the importance of novel
translational and clinical research and
its impact on health care overall.
This edition would not have been
made possible without the collective
help and support of several distinguished people. We would like to give
special thanks to our mentor David
Leitenberg, MD, PhD, associate
professor of microbiology, immunology, and tropical medicine at the
GW SMHS, and medical director
of fow cytometry and immunology
at Children’s National Hospital, for
his guidance as senior researcher and
advisor of Fusion. We would also like
to thank Thomas Kohout, director
of publications at GW, SMHS, and
Beaumont Society Co-Presidents
Zachary Falk and Zoe Shancer, for
their continued support and involvement with the publication of this edition. We are grateful to the Editorial
Board members (listed on the Table of
Contents) for their eforts and contributions to the journal.
We hope you enjoy this edition
of Fusion. We encourage you to contribute to the journal in our next issue!

Co-Directors:

Alice Chen, MSI
Isabel Park, MSI
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Performance Inspite of the Pandemic

David Leitenberg MD, PhD, associate
professor of microbiology, immunology, and
tropical medicine at SMHS, and medical
director of fow cytometry and immunology
at Children’s National Hospital
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To say it has been a challenging year
is an understatement. The COVID-19
pandemic affected our personal
and professional lives in a myriad of
ways. This was especially true of our
medical students pursuing research
activities. Because of COVID-19related restrictions on student access
to laboratory and clinical facilities,
as well as changes in clinical practice
which afected patient participation
in clinical trials, carefully considered
research plans were significantly
afected if not disrupted all together.
In light of these challenges, I am
very proud of the research accomplishments described in this year’s edition
of Fusion. Students demonstrated
remarkable flexibility and adapted
to COVID-19-related restrictions
on research activity by focusing on
what was feasible and changing plans
accordingly. For example, students
developed new skills in informatics
and applied that to the development
and statistical analysis of clinical
data-bases as well as to the analysis
of genomic and proteomic data. I was
particularly struck by how our students responded to the pandemic by
participating in COVID-19-related
community health eforts combined
with COVID-19-related research.
Several of our students were instrumental in developing databases to

collect clinical and laboratory information related to COVID-19-related
illnesses and response to therapy.
Some of this research has already
been assembled and published in peerreviewed journals and information
continues to be collected and analyzed
in ongoing longitudinal research.
As can be seen in the pages of
Fusion, medical student research
activity at GW is thriving and refects
a broad range of research interests
including basic science research,
clinical research, as well as research
in public health and health policy.
Data from our most recent graduating
class, indicated that 89% of students
participated in research while a
student in medical school, and 65
percent of students report publishing
a peer-reviewed manuscript, which
compares to a national average of
55%. This is a credit to the eforts of
our students and very importantly our
faculty mentors, who are essential for
this productivity. Congratulations to
all for your success!

David Leitenberg MD, PhD

associate professor of microbiology,
immunology, and tropical medicine
at SMHS, and medical director of
fow cytometry and immunology
at Children’s National Hospital
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CRISP-view: A Database of Functional
Genetic Screens Spanning Multiple Phenotypes
Anthony Chiu,
MSII
Corresponding
Authors: Yingbo
Cui,1 Xiaolong
Cheng,1 Qing
Chen,1 Bicna
Song,1 Yuan Gao,1 Tyson Dawson,1 Lumen
Chao,1 Wubing Zhang,1 Dian Li,1 Jijun Yu,1
Zexu Li,1 Teng Fei,1 Wei Li1
ADVISOR: Wei Li1
1 Center for Genetic Medicine Research,
Children’s National Hospital

T he pa i r i n g of C R ISPR /C a s9
gene editing with next-generation
sequencing technology has enabled
the scientific community to amass
large volumes of genetic knock-out
data on numerous cancer cell lines,
particularly within the last decade. As
a result, computational methods can
be applied to correlate cell survival
and proliferation with individual
genes across a cancer cell’s entire
genome.1 This presents a major opportunity to probe large-scale genetic
data for potential therapeutic targets.
However, efectively analyzing and
comparing these immense datasets
poses a signifcant challenge.
T he Mo d el - ba s e d A n a l y s i s
of Genome-w ide CRISPR/Cas9
Knockout with Visualization of
CRISPR Screens (MAGeCK-VISPR)
is an algorithm and visualization tool
previously developed to determine
novel essential genes and pathways
from CRISPR screening experiments.2 It assigns a numerical “betascore” to genes in order to rank

BASIC SCIENCE

their essentiality in cell survival and
CRISPR screening data to date.3
2
proliferation. MAGeCK-VISPR is
The construction of CRISP-view
a downloadable software which can
ofers a rich landscape of genetic data
be executed on the command line,
on numerous cancer cell lines. The
and it is currently one of the most
standardization of analysis from raw
favored and highly cited analytical
data sets, which allows comparability
models used for this purpose. The
between previously incomparable
aim of this project was to leverage this
samples, as well as the expansive
software to build a comprehensive,
volume of data are major strengths
standardized database of CRISPR
providing opportunity for further
screening data for the exploration
investigation. Future work will apply
and visualization of functional genes
data mining and machine-learning
across multiple cancer types.
approaches to this accumulation of
Raw data was retrieved from pubgenetic “big data” to better underlicly-available genome-wide CRISPR
stand cancer genetics and search for
screening data sets and was processed
therapeutic targets.
using the MAGeCKVISPR algorithm. We
performed systematic
The construction of CRISP-view offers a rich
analysis on all data sets
to assign nu merica l
landscape of genetic data on numerous
scores for the determination of essential
cancer cell lines.
genes. All samples were
annotated with fields
for cell line, organism,
REFERENCES:
treatment, controls, and sgRNA
1. Xing H, Meng LH. CRISPR-cas9: a
librar y used for knock-out. The
powerful tool towards precision medidata was organized and uploaded
cine in cancer treatment. Acta Pharinto a publicly available database
macol Sin. 2020;41(5):583-587. doi:10.1038/
s41401-019-0322-9
containing 10,321 human samples
and 825 murine samples from 167
2. Li W, Köster J, Xu H, et al. Quality
papers as of September 2020. Data is
control, modeling, and visualization of
presented on a web-interface which
CRISPR screens with MAGeCK-VISPR.
Genome Biol. 2015;16:281. Published 2015
allows researchers to search by cell
Dec 16. doi:10.1186/s13059-015-0843-6
line, tissue type, and treatment conditions. Positively and negatively
3. Cui Y, Cheng X, Chen Q, et al. CRISPview: a database of functional genetic
selected genes are ranked by betascreens spanning multiple phenotypes
scores computed by the MAGeCK[published online ahead of print, 2020
VISPR algorithm, and can be easily
Oct 3]. Nucleic Acids Res. 2020;gkaa809.
visualized along with quality control
doi:10.1093/nar/gkaa809
metrics and sample metadata on the
interface. This database, entitled
CRISP-view, currently represents
the most comprehensive database of
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Muhammad El
Shatanofy, MSII
Co-Authors:
Kristina M Pond,2
Rachel Schwartz,1
Amil R Agarwal,1
Lauryn Brown,1
Karuna Panchapakesan,3 Elmer Rajah,3
Austin Gillies,3 Dustin Hittel,4 Eric Hoffman,5
Heather Gordish-Dressman,1,3
ADVISOR: Laura L Tosi1,3
1 The George Washington University
2 The College of Medicine, University of
Kentucky
3 Center of Genetic Medicine, Children’s
National Hospital
4 Cumming School of Medicine, University
of Calgary, Alberta, Canada
5 Binghamton University State University of
New York

Osteoporosis is a chronic disease
characterized by low bone density,
disrupted bone microarchitecture,
and an increased risk for fractures.1
W h i le epidem iolog ica l st ud ies
have linked skeletal loading with
osteogenic responses, insufficient
research has explored the molecular
mecha nisms underly ing the
mechanical forces infuencing bone
mineral density (BMD). 1,2 Several
genetic va r ia nts of PIEZO1, a
mechanically activated ion channel,
have been associated with decreased
BMD and increased fracture risk.2,3
The purpose of this study was to
explore musculoskeletal phenotypes
associated with the PIEZO1 single
nucleotide polymorphism (SNP),
rs62048221, in two cohorts of healthy
young adults.
Cohorts: The Assessing Inherited
Markers of Metabolic Syndrome in
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the Young (AIMMY) was comprised
of the University of Calgary subgroup,
with healthy Caucasian young adults
(n=111; 61 males, 50 females; ages
18-35) and the Howard University
subgroup with African American
young adults (n=75; 21 male, 54 female,
ages 18-25) who were recruited as
part of a study to identify genetic
variants associated with risk factors
for metabolic syndrome. Functional
Single Nucleotide Polymorphism
Associated with Human Muscle
Size and Strength (FAMuSS) was
comprised of healthy young adult
Caucasians (n=370; 148 male, 222
female, ages 17-40) who participated
in a strengthening program of their
non-dominant (ND) arm for three
months.
Genotyping: This study used the
Applied Biosystems QuantStudio
7 Flex Real-Time PCR System and
Applied Biosystems Taqman Allelic
Discrimination Assays in genotyping
the FAMuSS and AIMMY cohort
DNA samples. Statistical Analysis: All
SNPs were tested for Hardy Weinberg
e q u i l i br i u m ( H W E ), a nd a g e
adjustments were made for each result.
Analysis of covariance (ANCOVA),
using additive genetic models, was
used to test relationships among
SNP genotypes and phenotypes for
bone quality. Statistically signifcant
associations under went post-hoc
pairwise comparisons and p-values
were adjusted using the Sidak method.
IRB: This study was approved by
the Children’s National Hospital
Institutional Review Board.
The genotype distribution for
rs62048221 of PIEZO1 was in Hardy
Weinberg equilibrium in the FAMuSS
and HU-AIMMY cohorts. Among
fema les in the FA MuSS cohort,
homozygous variants in rs62048221
were significantly correlated with

(3

Variations in PIEZO1 rs62048221 Associated with
Strength and Anthropometric Measures in Young Adults

Beaumont
Society

Research Prize
WINNER

lower baseline one arm strength
(p=0.0161) and percent change in one
arm strength (p=0.0214) in the nondominant arm. These associations
were not found in ma les in the
FAMuSS cohort. In the AIMMY
cohort, the TT genotype of rs62048221
in females was associated with a lower
hip circumference compared to
heterozygous females (p=0.0298).
CONCLUSIONS: This study expands
the known role of the PIEZO1 SNP
rs62048221 in musculoskeletal health
and bone development. The T allele
of rs62048221 has been associated
with decreased BMD in UK Biobank
samples.2 This study demonstrated a
new association between the T allele
and baseline one arm strength and
percent change in one arm strength
in the non-dominant arm among
fema les in the FA MuSS cohort.
This association was not observed
for males in the FAMuSS cohort
nor among males or females in the
AIMMY cohort. The decrease in arm
strength may help explain the results
of past researchers, who associated
polymorphisms in mechanosensitive
genes with decreased distal radius and
forearm BMD.4,5 Further research is
warranted to explore the biological
mechanisms underlying the infuence
of rs62048221 on BMD. Elucidation of
PIEZO1 and other genetic variants
that impact bone mineral density
would be useful in planning exercise
and care regimens for those at higher
risk of fracture through their genetic
variants.
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Cardiovascular disease remains
the major cause of death in developed countries, with atherosclerosis
leading to approximately 650,000
myocardial infarctions (MI) each
year in the United States. 1 While
the current diagnostic gold standard
for coronary artery disease (CAD)
is coronary angiography via cardiac
catheterization, less invasive blood
tests identifying a regulatory T-cell
(Treg) imbalance have shown impressive sensitivity and specificity for
CAD.2 Whole blood RNA analyses
via single-molecule next-generation
sequencing (NGS) of RNA (RNAseq)
have identifed transcripts associated
with CAD (TRACs) that illustrate an
mRNA signature of a Treg-like defect
in CAD patients (Figure 1). Results
have been variable, however, based on
the specifc single molecule sequencer
product employed. The prospect of
an accurate and reliable blood test
to predict the development of atherosclerosis excites many and would
fundamentally alter the diagnostic
landscape for CAD.
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Treg progenitor

FIGURE: Schematic representation of Treg-related TRACs identifed by RNAseq
The objective of the study was
to determine the degree of reproducibility among the primary techniques previously used to identify and
quantify the Treg imbalance underlying atherosclerosis. Specifically,
we examined the single molecule
sequencers from SeqLL and Illumina.
Determining the degree of reproducibility of these sequencers would
enable investigators to d iscern
superior techniques and ultimately
empower clinicians and to make use
of the most reliable methods.
W hole blood R NA was a nalyzed by single-molecule next-generation sequencing (NGS) of RNA
(RNA-Seq) to identify TRACs in
a discovery group and a validation

group presenting for coronary catheterization. Whole blood RNA was
depleted of ribosomal RNA (rRNA)
and then sequenced on a SeqLL Single
Molecule Sequencer. The resulting
short reads were aligned to the human
transcriptome and the number of
reads per kilobase of exon per million (RPKM) was determined and
compared between groups by a combined fold-change/p-value flter. This
model was replicated in an additional
study, and an identical design was
undertaken using a sequencer from
Illumina, and transcript reads were
analyzed by sequencer product.
Sequencing identifed a profle of
Treg imbalance in patients with even
Continued on p. 10

9

Continued fom p. 9
mild coronary stenosis (>20%) as confrmed on coronary angiography. The
SeqLL platform identified a subset
of 39 transcripts highly-associated
with CAD that were replicated in a
follow-up study (p<0.001), while the
Illumina follow-up study displayed
minimal meaningful overlap with its
initial fndings.

Conclusion: The SeqLL sequencing
platform of amplifcation-free, single
molecule sequencing seems to be
more reproducible than the amplifcation-dependent Illumina NextSeq.
Future investigations will be directed
toward establishing a clinically relevant amplifcation-free method of
quantifying RNA in patient blood.
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The vertebrate immune system has
receptors that recognize a wide
range of viral nucleic acids during
an infection and elicit a robust antiviral response. Retinoic acid-inducible gene-I (RIG-I) and Melanoma
Differentiation-Associated protein 5 (MDA5) are two such pattern
recognition receptors (PRRs) that
stimulate a type I interferon (IFN)
response against a variety of double
stranded ribonucleic acid (dsRNA).1
While proper functioning of these
receptors is critical for reducing viral
spread, mis-regulation of MDA5 or
RIG-I can result in autoinfammatory conditions such as Systemic
Lupus Erythematosus (SLE), AicardiGoutières syndrome (AGS), and
Singleton-Merten syndrome (SMS).2
Previous research suggests that
the ATPase active site of these receptors acts as an allosteric modulation
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FIGURE:
site, playing a role in altering the
confirmation of RIG-I and MDA5
and thereby afecting their signaling
activity.3 Our group has examined several mutations in the ATPase site that
result in loss of the ATPase activity.
While the dsRNA binding capabilities remained intact, these mutants
displayed signifcant changes in signaling activity. Half of these mutant
proteins showed a hyper-signaling
phenotype, while the other half displayed a complete loss of signaling.
This fnding has been our rationale
for targeting the ATPase site with
small molecule intervention. In this
study, we have used a biochemical
assay to screen for thousands of small

molecules to identify potential hits
that inhibit the ATP hydrolysis capabilities of RIG-I and MDA5. These
hits were then further characterized
using cell-signaling and cell-free
assays to delve into the mechanism
of inhibition. More specifcally, these
assays served to identify whether
downstream mediators in the RIG-I
and MDA5 pathways were inhibited
or activated by the compounds.
MDA5 and RIG-I were recombinantly expressed in a strain of E.
coli. These cells were lysed, and the
proteins were purifed using afnity
and size-exclusion chromatography.
RNA was prepared using in vitro
transcription with bacteriophage
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RNA polymerase and gel electrophoresis. The ATP hydrolysis assay was
implemented in screening thousands
of small molecules from various
libraries. The reaction was initiated
when a mixture of RNA and ATP was
added to pre-incubated protein and
compounds. The optical densities of
the samples were then measured to
gauge ATP hydrolysis. After initial
screening, electrophoretic mobility
shift assay (EMSA) was performed
by incubating MDA5, RIG-I, RNA,
and the small molecule compounds.
Gel electrophoresis with SYBR gold
staining was used to determine how
these compound inf luence RNA
binding. Finally, IRF3 dimerization
(downstream transcription factor)
was studied to assess whether the
compounds upregulate or downregulate the MDA5/RIG-I signaling
pathway.

BASIC SCIENCE

Compou nds were nu mbered
rather than named to maintain confidentiality. After the compound
screening, “hits” were classified as
compounds that were successful in
inhibiting ATP hydrolysis (Figure
A). The EMSA showed that some
compounds were able to interrupt
protein-RNA binding at high doses
of the compound (Figure B). IRF3
dimerization occurs only when the
protein and RNA are both present,
and dimerization indicates an activation of the downstream signaling
process (Figure C). Illustrated in
Figure D, certain compounds were
able to interrupt the IRF3 dimerization, indicating that these compounds
were successful in inhibiting the
MDA5 signaling cascade. Compounds
such as Compound 17 were especially
potent in inhibiting this step even at
lower concentrations.

Conclusions: Among the hits were
inhibitors of several known enzymes
such as certain dehydrogenases,
Cytochrome P40, topoisomerase, and
cyclooxygenase. Identifying inhibitors these pathways has implications
in therapy for autoinf lammatory
conditions. Future experiments will
implement additional cell-based
assays to further characterize the hits.
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The well documented plasticity of the
mammalian brain suggests a role for
environmental experience in modulating brain development.1 Indeed,
environmental enrichment (EE) has
been championed as a robust and noninvasive approach to augment white
matter health.1,2 This experimental
paradigm, which exposes animals to
increased social interactions, novel
stimuli, and voluntary exercise, is a
powerful promoter of neuroplasticity
that leads to functional improvement
in neurological injury models, such as
premature birth.1,2 Recent work has
demonstrated that this neuroplasticity increases activity-regulated
changes in myelin forming cells,
including oligodendrocyte precursor
cell (OPC) proliferation, oligodendrogenesis, and modulations in the
thickness and number of myelinated
axons.3-5 We previously reported that
early and continuous EE attenuates
cellular, behavioral, and ultrastructural defcits caused by hypoxic brain
injury by stimulating oligodendrocyte maturation, myelination, and
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FIGURE: Environmental enrichment increases the thickness of P60 myelinated
axons in normal development. A) Experimental groups B) Representative electron
microscopy image from NX white matter C) Representative electron microscopy image
from EE white matter D) Scatter plot of g-ratios of corpus callosum axons in comparison
to axon caliber in NX vs EE E) Qualifcation of myelinated axon number in the corpus
callosum (n=4 per group)
functional recovery.1 While the value
of an EE intervention after adult
injury has been demonstrated, 2 the
utility of EE in normal development,
especially in glial development, has
not been fully elucidated. Here, we
aimed to understand whether EE
afects normal developmental myelination through adulthood.
Mice were randomly assigned to
be housed in an enriched environment or standard environment cages.
The enriched environment condition

consisted of clear Plexiglas cages (24
cm W x 20 cm H x 46 cm L) that
had either wooden blocks or metal
link chains hanging from the roof,
a running wheel, a series of plastic
“habit-trails” of diferent confgurations, and several balls and other
objects spread over the foor. These
objects were changed every 3 days to
preserve novelty. The standard environment protocol consisted of smaller
cages (16 cm W x 13 cm H x 37 cm L)
without any of the novel objects that
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mice housed in an enriched environment had. Furthermore, while control
mice were reared in groups of 2-5
animals per cage, mice housed in an
enriched environment were reared
in groups of 8-12 animals per cage.
Immunohistochemistry and electron
microscopy analysis was performed.
An inclined beam-walking test was
used to examine diferences in subcortical white matter myelination
between experimental and control
groups. The time that it took each
mouse to reach the target at the top
of the inclined beam as well as the
number of foot slips was documented.
Analysis was performed at postnatal
day (P) 60.
We first assessed the effects of
prolonged EE on OPCs and proliferating OPCs versus normoxic (NX)
controls and found no changes in
oligodendrogenesis in response to
EE. To examine efects of myelination
at the ultrastructural level, we performed electron microscopy analysis
on the corpus callosum of P60 mice.
In comparison to NX mice, EE mice
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had axons with thicker myelin, as
indicated by lower g-ratio values
(Figure). Furthermore, enriched mice
had improved motor coordination on
a beam walking test, as demonstrated
by the decreased number of foot slips.
No significant difference between
groups was noted for the amount of
time that it took to reach the target.
Conclusions: The cellular, ultrastructural, and behavioral experiments conducted in this study demonstrate that prolonged EE, comprised of enhanced exposure to novel
stimuli, socialization, and locomotor
activity, can increase developmental
myelination and lead to functional
improvement in behavior. Hence, EE
can play a benefcial role in normal
development. Future research should
work towards translating EE protocols into clinical interventions for
improving locomotor function.

REFERENCES
1.

white matter recovery. Nature communications, 11(1), 964. https://doi.org/10.1038/
s41467-020-14762-7
2. Forbes TA, Gallo V. (2017). All Wrapped
Up: Environmental Efects on Myelination. Trends in neurosciences, 40(9),
5 7 2 – 5 8 7. ht t p s : //d oi .or g / 10 . 101 6/ j .
tins.2017.06.009
3.

Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, et al. (2014). Neuronal
activity promotes oligodendrogenesis
and adaptive myelination in the mammalian brain. Science (New York, N.Y.),
344(6183), 1252304. https://doi.org/10.1126/
science.1252304

4. Liu J, Dietz K, DeLoyht JM, Pedre X,
Kelkar D, et al. (2012). Impaired adult
myelination in the prefrontal cortex of
socially isolated mice. Nature neuroscience, 15(12), 1621–1623. https://doi.
org/10.1038/nn.3263
5.

Zhao YY, Shi XY, Qiu X, Lu W, Yang S, et
al. (2012). Enriched environment increases
the myelinated nerve fibers of aged rat
corpus callosum. Anatomical record
(Hoboken, N.J. : 2007), 295(6), 999–1005.
https://doi.org/10.1002/ar.22446

Forbes TA, Goldstein EZ, Dupree JL,
Jablonska B, Gallo V, et al. (2020). Environmental enrichment ameliorates perinatal
brain injury and promotes functional

--

13

SARS-CoV-2 specifc T-cell Epitopes and in
Silico HLA restriction Predictions
Zoë Shancer,
MSII
ADVISORS:
Michael Keller,
MD1,2,3 and
Catherine Bollard,
MD1,3,4
1 Center for Cancer and Immunology
Research, Children’s National Hospital
2 Division of Allergy and Immunology,
Children’s National Hospital
3 The George Washington University
Cancer Center,
4 Division of Blood and Marrow
Transplantation, Children’s National Hospital

Understanding T-cell responses
to SARS-CoV-2 is crucial for the
development of vaccines and adoptive immunotherapy. The HL A
presentation of antigenic peptides
in particular is essential for generating robust T-cell responses against
SA RS - CoV-2, which may affect
susceptibility to and severity of
SARS-CoV-2 infection. The purpose of this study was to determine
whether SARS CoV-2-specifc T-cell
epitopes identified in convalescent
patients are predicted to be restricted
through a wide range of both class
I and class II HLA molecules. The
study also aimed to determine the
stability of SARS-CoV-2 predicted
epitopes.
T-cell epitope mapping of structural proteins was done using minipools containing 5–12 peptides each,
with responses measured via IFN-g
ELISpot. Once SARS-CoV-2 specifc
T-cell epitopes were identifed, predictive algorithms were used to determine HLA restriction predictions
for each epitope of membrane, spike,
nucleocapsid and envelop proteins.

14

The predictive algorithms used were
NetMHCIIPan and MARIA, which
provide percent rank scores, normalizing prediction scores by comparing
epitopes to a set of random peptides.1,2 The stability of SARS-CoV-2
predicted epitopes was determined
through identifcation of and comparison to known SARS-CoV-2 genetic
variants in available literature.
T- cel l e pito p e s w it h i n t he
C-terminus of membrane protein
were identifed at amino acids (AA)
144–163 and 173–192, which were
recognized by 8 and 6 convalescent
donors respectively. Mapping of spike
epitopes demonstrated three regions
at AA 57-75, 205–224, and 449–463,
which were recognized by 3 donors.
Mapping of nucleocapsid epitopes
revealed two regions at AA 257-271
and 313-335, which were recognized
by three donors.
A ll membrane epitopes were
pred icted to be M HC Class II
restricted. In silico analysis suggested restriction of these epitopes
through HLA-DR11, DR7, DQ3,
and DQ7. Nucleocapsid epitopes
between AA 257-271 were predicted
to be Class II restricted. Strong
binders included HLA-DPA1*02:01
and HLA-DPB1*14:01. Two nucleocapsid epitopes between AA 313-335
were Class I restricted. Five spike
epitopes were predicted to be Class II
restricted through HLA-DRB1*03:01,
HLA-DRB3*01:01, HLA-DPA1*01:03,
HLA-DPB1*02:01.
One known SARS-CoV-2 genetic
variant within membrane protein,
T175M, overlaps with predicted
peptide 44. One nucleocapsid variation, T271I, overlaps with predicted
epitope 65. Two known spike mutations overlap with predicted epitopes:
N74K mutation with peptide 15 and
S221W with peptide 53.

Conclusions: In silico analysis predicted HLA restriction of membrane
protein epitopes through alleles
which are present in approximately
50% of the population.3 Identified
membrane, nucleocapsid, and spike
epitopes appear to be genetically
stable, as known variants are point
mutations that do not overlap with
anchor residues. Further study is
needed to better understand the biologic activity of SARS-CoV-2 T-cells
of various restrictions. It will be
critical to determine if there are risk
associations with specifc HLA types.
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Table 1: Identified Class II Epitopes in Membrane, Nucleoprotein, and Spike proteins and predicted HLA restrictions
Membrane
Peptide sequence

LRGHLRIAGHHLGRC

LRIAGHHLGRCDIKD

Amino acid
location

Subject

HLA-DRB1

HLADRBJ

HLA-DRB4

HLA-DQA1

HLA-DQB1

HLA-DPA1

HLA-DPB1

144-159

257

07:01, 11:04

02:02

01:03

02:01, 05:01

03:01, 03:03

01 :03, 02:01

03:01, 03:03

262

07:01, 11:01

02:02

01:01

02:01, 05:01

02:02, 03:01

01 :03, 03:01

04:01, 11:01

265

11:04, 15:02

02:02

01 :01, 01 :03

01 :03, 05:01

03:01, 06:01

01 :03, 02:01

02:01, 14:01

01 :02, 05:01

03:01, 06:02

01 :03, 02:01

04:01, 14:01

02:01, 05:01

03:01, 03:03

01 :03, 02:01

03:01, 03:03

01 :03, 05:01

03:01, 06:01

01 :03, 02:01

02:01, 14:01

148-163

270

11:04, 15:01

02:02

257

07:01, 11:04

02:02

01:03

265

11:04, 15:02

02:02

01 :01, 01 :03

HLADRBS

01:02

01:02

262

07:01, 11:01

02:02

01:01

02:01, 05:01

02:02, 03:01

01 :03, 03:01

04:01, 11:01

265

11:04, 15:02

02:02

01 :01, 01 :03

01:02

01 :03, 05:01

03:01, 06:01

01 :03, 02:01

02:01, 14:01

269

12:01, 15:01

02:02

01:01

01:01

01 :02, 05:01

03:01, 05:01

01 :03, 01 :03

02:01, 04:01

270

11:04, 15:01

02:02

01 :02, 05:01

03:01, 06:02

01 :03, 02:01

04:01, 14:01

273

03:02, 16:02

01:62

01 :01, 01 :03

01 :02, 04:01

04:02, 05:02

02:02, 02:02

01:01, 01:01

275

01 :01, 03:01

01:01

01:01, 01:03

01 :01, 05:01

02:01, 05:01

01 :03, 01 :03

02:01, 02:01

262

07:01, 11:01

02:02

01:01

02:01, 05:01

02:02, 03:01

01 :03, 03:01

04:01, 11:01

269

12:01, 15:01

02:02

01:01

01:01

01 :02, 05:01

03:01, 05:01

01 :03, 01 :03

02:01, 04:01

273

03:02, 16:02

01:62

01:01, 01:03

02:02

01 :02, 04:01

04:02, 05:02

02:02, 02:02

01:01, 01:01

275

01:01, 03:01

01:01

01:01, 01:03

01 :01, 05:01

02:01, 05:01

01 :03, 01 :03

02:01, 02:01

181-195

275

01 :01, 03:01

01:01

01:01, 01:03

01 :01, 05:01

02:01, 05:01

01 :03, 01 :03

02:01, 02:01

KPRQKRTA TKAYNVT

257-271

276

04:01, 07:01

01:01

01:03

03:01, 05;05

03:01, 03:02

02:01, 02:01

14:01, 14:01

AFFGMSRIGMEVTPS

313-327

270

11:04, 15:01

02:02

01 :02, 05:01

03:01, 06:02

01 :03, 02:01

04:01, 14:01

PFFSNVTWFHAIHVS

57-71

259

03:01, 13:01

01:01

01:03

01 :03, 05:01

02:01, 06:03

01 :03, 01 :03

04:01, 04:01

NVTWFHAIHVSGTNG

61-75

259

03:01, 13:01

01:01

01:03

01 :03, 05:01

02:01, 06:03

01 :03, 01 :03

04:01, 04:01

SKHTPINLVRDLPQG

205-219

291

03:01, 04:01

01:01

01:03

03:01, 05:01

02:01, 03:02

01 :03, 01 :03

02:01, 03:01

PINLVRDLPQGFSAL

209-223

273

03:02, 16:02

01:62

01:01, 01:03

01 :02, 04:01

04:02, 05:02

02:02, 02:02

01:01, 01:01

291

03:01, 04:01

01:01

01:03

03:01, 05:01

02:01, 03:02

01 :03, 01 :03

02:01, 03:01

291

03:01, 04:01

01:01

01:03

03:01, 05:01

02:01, 03:02

01 :03, 01 :03

02:01, 03:01

SRTLSYYKLGASQRV

SYYKLGASQRVAGDS

LGASQRVAGDSGFAA

173-188

177-192

02:02

Nucleoprotein

Spike

YNYL YRLFRKSN LKP

449-463

Red: strong binder (<2). Green: Weak binder (2-10)

Table 2: Identified Class I Epitopes in Nucleoprotein and predicted HLA restrictions
Peptide sequence

Amino acid
location

Subject

MSRIGMEVTPSGTWL

317-331

270

GMEVTPSGTWL TYTG

321-335

270

HLA-A

HLA-B

HLA-C

24:02, 26:01

40:01,

44:os· 02:02, 03:04

24:02 26:01

40:01

44:os• 02:02 03:04

Red: strong binder (<2). Green: Weak binder (2-10). * Predicted B*44:05 peptide: GMEVTPSGTW
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Resea rch productiv it y has
traditionally been a key determinant
for professional advancement within
academic medicine. 1 In the past,
productiv it y has been assessed
using simple numeric measures
such as publications and citation
counts. However, these metrics only
measure quantity and are unable
to provide insight regarding the
quality of a researcher’s publications.
In recent years, there has been a
push to move past these simple
measures of productivity. 1,2 J. E.
Hirsch first proposed the H-index
in 2005 as a bibliographic metric
to objectively assess the quality of
a researcher’s publications.3 While
originally developed for use in the
natural sciences, 3 its association
w it h academ ic r a n k h a s si nce
been validated by studies within a
variety of both medical and surgical
specialties. 4,5 To our knowledge, no
prior studies have evaluated academic
i mpact by or thopaed ic trau ma
surgeons on faculty at fellowship
training programs. The purpose of
this study is to assess the association

I•
I
I •
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FIGURE 1: H-Index versus number of citations and publications plotted on
logarithmic scale
between H-index and academic rank
H-indices of 322 orthopaedic trauwithin this cohort.
matologists from 57 OTA fellowship
This is a cross-sectional study
programs were organized and calcuof full-time orthopaedic surgeons
lated. Additionally, the total number
a ff i l iated w ith
orthopaedic
[O]ur fndings indicate that H-index, number
trauma association
(OTA) fellowship
of citations, and number of publications
prog ra ms i n t he
United States. The
study population
are strongly correlated with academic rank
wa s constr ucted
by q uer y i n g t he
among full-time orthopaedic trauma surgeons
Orthopaedic
Trauma Association
affliated with fellowship training programs.
(OTA) website to
obtain a complete
record of all OTA-afliated orthoof publications, academic rank, and
paedic traumatolog y fellowship
fellowship training pedigree were
training programs. A total of 62
also collected. Data normality was
programs were identifed. For each
assessed using the Shapiro-Wilk
program, the department website was
test. Variance was assessed using
used to generate a list of faculty memKruskall-Wallis test for non-parabers with primary appointments. The
metric data that were not normally
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distributed due to skew and outliers.
Post-hoc analysis on non-normally
distributed data was performed using
Mann-Whitney test with Bonferroni
correction. Median differences for
non-normal data were determined by
Hodges-Lehman estimation.
Overall, these 322 surgeons have
published 14,822 publications. The
total H-index for this group of surgeons is 4,136. Number of publications is a stronger predictor of
H-index than number of citations (p
< 0.0001). Number of publications,
number of citations, and H-Index
tend to increase with academic rank
(p < 0.001). There exists no signifcant trend with respect to afliated
training amongst the various academic ranks. Orthopaedic trauma
versus other orthopaedic sub-specialty fellowship training is not a
predictor of academic rank (p 0.11).
There exist no geographical diferences with regards to academic rank
and training afliation (p 0.79). There
is no statistical diference in research
productivity for those with afliated
training pedigree versus those not
afliated with respect to number of
publications (p 0.44), number of citations (p 0.62), and H-Index (p 0.59).
In conclusion, our fndings indicate that H-index, number of citations, and number of publications
are strongly correlated with academic
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FIGURE 2: Number of publications by academic rank in box-and-whisker (A) and
histogram (C) plots H-index by academic rank in rank in box-and-whisker (B) and
histogram (D) plots
rank among full-time orthopaedic
trauma surgeons afliated with fellowship training programs. While
research productivity is not the only
benchmark for achievement in academic medicine, it has historically
been considered a key determinant
for professional advancement. Our
fndings suggest the H-index may be a
useful metric for evaluating academic
impact within the feld of orthopaedic
trauma surgery.
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The purpose of this study is to compare MCR and MCD reimbursement
rates for 12 orthopaedic procedures
performed to treat common fractures of the upper extremity. Upper
extremity injuries account for approximately 10% of traumas presenting
to emergency departments in the
United States and represent a signifcant source of health care spending.1
Secondary to both a growing population and increasing life expectancy, it is also anticipated that more
Americans will continue to enroll
in Medicare (MCR) and Medicaid
(MCD). 2,3 Given the increasingly
large number of patients covered by
government-run healthcare programs,
it is critical that a sufcient number
of orthopaedic surgeons participate
with these payers. However, MCD
is a federal-state program, and the
guidelines put forth by the Centers
for Medicare and Medicaid Services
(CMS) allow for each state to determine access and MCD reimbursement rates.4 Large discrepancies have
been reported between MCD and
MCR reimbursement for identical
procedures.5 Such inconsistencies in
reimbursement may act as a barrier to
MCD patients gaining access to timely
orthopaedic care.
Twelve orthopaedic procedures

18

TABLE 1: Medicaid, Medicare, and Medicare Wage Index Adjusted Medicair
Reimbursement Data presented as Mean$ ± SD, MedianS with range, and coeffcient of
variation for reimpbursement
Mean (SD)
Median <Ranee)
Medicare Reimbursement
Shoulder Arthron!astv
1473.9 (93.55)
1467.93/1353.37-1929.14)
1218.63(77.23)
1212.69(1119.53-1590.95)
Shoulder Hemiarthroolastv
Proximal Humerus ORIF
894.26(56.53)
887.26(822.65-1159.20)
1477.3904(96.77)
1467.63(1355.55-l 929.40)
Total Elbow Arthroolastv
Distal Humerus ORIF
943.1146(61.88)
934.22(865.29-1222.0 I)
662.681(43.4
654.365(607.29-850.56)
Radial Head ORIF
Radial Head Arthroplastv
692.486(45.36)
685.715(635. 78-894.61)
515.784(32.85)
5 I0.06(472.55-661.27)
Radial Head Excision
891.187(56.68)
883.535(818.32-1151.96)
Humeral Shaft ORIF
Humeral Shaft IMN
871.3786(55.43)
864.275(799.55-l 129.60)
Olecraoon ORIF
661.4132(42.14)
654.93(606.05-849.00)
729.4216(46.41)
723.335(669.27-940.6 l)
Clavicle ORJF
Total
919.30(308.62)
862.11( 472.55-1929.40)
Medicaid Reimbursement
Shoulder Arthron!astv
I 181.261321.56\
1136.485/515.5-2219.63)
944.24(244.09)
Shoulder Hemiarthroplastv
933.46(515.5-1830.52)
650. 77(189.48)
644.74(211-1333.75)
Proximal HumerusORIF
1141.79(308.93)
l 122.655(463.95-2219.93)
Total Elbow Arthroplastv
Distal Humerus ORIF
684.31(211-1406.02)
676.13(208.64)
483.54(140.66)
486.33(151-978.64)
Radial Head ORIF
544.5(242.29-1123.7)
Radial Head Arthroolastv
561.65(166.9'
3 87.54(134-760.84)
Radial Head Excision
396.45(107.6 I)
664.08(192.34 I
671.92/211-1325.43)
Humeral Shaft ORIF
676.1(175.25
664.45(211-1299.7)
Humeral Shaft !MN
Olecraoon ORIF
497.83(145.75)
502.59(128.88-976.84)
507.6(165.08)
511.5(151-1082.25)
Clavicle ORJF
701.08(328.41)
612.66(128.88-2219.93)
Total
Medicare Wage Index Adjusted Medicaid Reimbursement
1083.24/392.91)
98 l .72/537.15-2802.06)
Shoulder Arthroolastv
874.96(317.65)
769.3(449.12-2310.85)
Shoulder Hemiarthroplastv
Proximal Humerus ORJF
603.08(240.22)
550.71(234.97-1683. 73)
1047.73(391.67)
929.95(483.44-2802.44)
Total Elbow Arthroplastv
624.48(255.01)
579.26(234.97-1774.96)
Distal Humerus ORIF
Radial Head ORIF
447.08(175.79)
406.22(18.15-1235.44)
518.2/191.16)
458.66/252.47-1299.43)
Radial Head Arthroolastv
366. 79/134.89)
326. 74(149.22-960.48)
Radial Head Excision
613.1(236.59)
558.77(234.97-1673.22)
Humeral Shaft ORIF
624.85(223.74)
564.92(234.97-1640. 74)
Humeral Shaft IMN
417.44(134.29-1233. 16)
458.96(177.8 I)
Olecraoon ORIF
Clavicle ORJF
470.07(201.98)
440.61(161.15-1366.23)
Total
642.94(339.28)
55l.21(134.29-2802.44)

performed for the treatment of
common upper extremity fractures
were selected for analysis. The 2020
MCR reimbursement rate was collected for each procedure for each
state from the Medicare Physician
Fee Schedule Database. MCD reimbursement rates were obtained from
each state’s physician fee schedule
database. Reimbursement rates were
then compared by assessing the ratio
of MDC to MCR, the dollar diference
in MCD to MCR reimbursement, and
the diference per relative value unit
(RVU) to adjust for the diference in
procedure complexity.2,3 The range
of variation in MCD reimbursement

Coefficient of Variation
0.06
0.06
0.06
0.07
0.07
0.07
0.07
0.06
0.06
0.06
0.06
0.06
0.34
0.27
0.26
0.29
0.27
0.31
0.29
0.3
0.27
0.29
0.26
0.29
0.33
0.47
0.36
0.36
0.4
0.37
0.41
0.39
0.37
0.37
0.39
0.36
0.39
0.43
0.53

and MCR wage index-adjusted MCD
reimbursement was calculated, as
well as the coefficient of variation.
Comparisons in reimbursement were
calculated using coefcient of variation and student T tests to evaluate the
diferences between the mean MCD
and MCR reimbursements.
There was statistically signifcant
difference in reimbursement rates
between MCR and MCD for all 12
procedures, with MCD reimbursing
on average 46.5% less than MCR. In
40 states, MCD reimbursed less than
MCR for all 12 procedures. Regarding
the dollar diference per RVU, MCD
paid on average $18.03 less per RVU
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than MCR. There was substantial
variation in reimbursement per RVU,
ranging from $69.22 less per RVU
(New Jersey, radial head ORIF) to
$45.47 more per RVU (Illinois, radial
head arthroplasty) for MCD. The
coefcient of variation for MCD reimbursement ranged from 0.26 (shoulder
hemiarthroplasty and humeral shaft
IMN) to 0.33 (clavicle ORIF). This is
in stark contrast with the signifcantly
lower variability observed in MCR
reimbursement, which ranged from
0.06 to 0.07 for all procedures.
The findings of this study call
attention to the significant variability in reimbursement that exists
among state MCD programs for 12
orthopaedic procedures commonly
used to treat fractures of the upper
extremity. This exceeded the variation seen in MCR reimbursement
for the same group of procedures.
Additionally, MCD reimbursement
was signifcantly lower than MCR for
all 12 procedures. Such discrepancies
may act as a barrier, preventing many
MCD patients from accessing timely
orthopaedic care. Implementing more
uniform and robust reimbursement

TABLE 2: Dollar differences between Medicaid and Medicare reimbursement Data
presented as a Mean$ ± SD, MedianS with range and percent difference Negative
values indicate lower Medicaid reimbursement when compared to Medicare
Mean(SD)
Dollar Difference between MCD and MCR
-293.81(316.85)
Shoulder Arthroolastv
Shoulder
Hemiarthronlastv
-275.95/236.95)

¾ Difference

Median (ranee)

Pvalue

Coefficient of Variation

-307. 7(-1020.78-663.33)

-34.49/42.41)

<0.001

-1.08

-264.42/-809.92-239 .57)

-38.07/39.9)

<0.001

-0.86

-244.64/183.99)

-236.87ff- 769.77-174.55))

-51.23/60.62)

<0.001

-0.75

-336.84/305.61)
-268.23(208.46)
-180.01/140.5)

-324.205/-1073.! 1-290.53)
-246.24/-820. I 9- I 84.0 I)
-155.53/-578.69-l28.08)

-40.73/50.42)
-57.64(73.68)
-52.61/67.6])

<0.001
<0.001
<0.001

-0.91
-0.78
-0.78

-131.75/167.68)
-l20.01/!07.7ll

-127.93/-480.96-425.63)
-l20.59(-434.51-99.57)

-34.27/44.05)
-42.35/56.05)

<0.001
<0.001

-1.27
-0.9

-228.29/191.29)
-196.43(173.71)

-205.21 <765.32-113.4 n
-193.94(-741.64-l 70.l)

-49.28(64.7)
-40.14(55.72)

-164.46(145.65)
-222. 79/161.36)

-l42. I 7(-577.23-127.84)
-205.58/-649.44-l4l .64)

-52.07(83.88)
-65.16/85.27)

<0.001
<0.001
<0.001
<0.001

-0.84
-0.88
-0.89
-0.72

-221.62/2l1.5n

-192.51(-1073.11-663.33)

-46.53/62.26)

<0.001

-0.95

Proximal Humerus

ORIF
Total Elbow

Arthro lastv

Distal Humerus ORJF
Radial Head ORIF
Radial Head

Arthro lastv
Radial Head Excision
Humeral Shaft ORIF

HumeralShaft lMN
Olecranon ORIF

ClavicleORIF
Total

models may increase access to care for
the millions of MCD benefciaries in
the United States.

3.
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Improving high quality, respectful
maternity care is a global priority
to advance maternal and neonatal
health.1 Globally, mistreatment of
women during maternity care is

widespread. Recent data from the
United States (US) suggest that one
in six women reported experiencing
one or more types of mistreatment.2
Immigrant women, in particular, face
a myriad of assaults to their basic civil
rights, potentially leading to lower
health status. Despite lower access to
prenatal care and increased reports of
discrimination, stigma, and infringements on reproductive rights, the
maternity care experiences of immigrant women remain understudied.
This article extends the literature
of person-centered maternity care
(PCMC) by applying recently validated measures and frameworks to a
US context.3, 4 Specifcally, this study
focuses on Mexican and Chinese
immigrant women, two of the largest

TABLE: Participant Characteristics
Mexican

Chinese/
Taiwanese

Total

n=10

n=8

n=18

Mean

38

34 4

36 4

≤30

2

3

5

31-40

2

4

6

>40

6

1

7

Naturalized

1

1

2

Permanent Resident

0

5

5

Work Permit

3

1

4

Overseas Born Citizen

0

1

1

Undocumented

6

0

6

Mean

20

11 9

16 4

LA

5

5

10

OC

5

3

8

10 (100%)

3 (37 5%)

13 (72 2%)

Age (years)

Legal Status

Time in US (years)
County

Undocumented family or friends

20

immigrant populations in the U.S.
The Research on Immigrant
Health and State Policy Study is a
convergent parallel mixed methods
study examining the lived experiences
of Latino and Asian immigrants in
California. Semi-structured, in-depth
inter views were conducted from
August 2018 to August 2019 with
Mexican and Chinese women living
in Los Angeles or Orange County
who gave birth within the past two
years. Interviews (n=18) were conducted by nine bilingual interviewers,
transcribed, and subsequently coded.
Coded data were mapped onto the
domains of PCMC.
Women described several preferences when establishing prenatal care,
including provider qualifcations, linguistic, and ethnic concordance. Most
Chinese women who actively sought a
specifc provider cited linguistic and
ethnic concordance as their main
criteria. Across ethnicity, county, and
immigration status, women shared
the expectation that more difficulties arose for those who did not speak
English.
Almost all participants spoke of
an overall positive experience, yet
the majority of women pinpointed
instances of mistreatment. Negative
experiences ranged from long wait
times to acts of disrespectful care such
as denial of necessary medical care.
Many women described specifc negative encounters such as feeling rushed,
judged, and blamed by providers.
Translation services were often
quoted as unavailable or f lawed.
However, Mexican women, overall,
reported greater ease of accessing
translation services or bilingual providers compared to Chinese participants. For women who spoke English
well, or attended clinics with bilingual
staf or adequate translation services,
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language and cultural concordance
were not defining features in their
perception of care.
Some women utilized informal
support systems to enhance communication such as enlisting a family
member to assist in translating or
using available technology to overcome language barriers. Chinese
women, in particular, were more likely
to utilize these strategies to enhance
their care experience.
To our knowledge, this study is the
frst to apply concepts of PCMC to a
US context, particularly among immigrant women. Our fndings are in line
with other research that suggests poor
patient-centered care among communities of color in the U.S.5
There is signifcant overlap with
our study findings and the experiences of lower status women in
international contexts. However, it

is also important to highlight areas
that may be uniquely specifc to the
US immigrant context. These include
judgements related to fertility, language challenges, and preferences for
cultural concordance with providers.
Understanding immigrant experiences of respectful maternity care can
ofer insight to clinicians and policymakers, and contextualize the future
of patient-centered care research and
its intersection with immigrant life
in the U.S.
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In the last five years, mechanical
thrombectomy has revolutionized
the standard of care for patients suffering from acute stroke.1 The cost
of mechanical thrombectomy procedures has been shown to cost more
than traditional medical therapy. 2
Still, the mechanical thrombectomy
procedure for acute stroke contributes
to a greater cost-efective outcome in
terms of quality-adjusted life years
(QALY ) and reduces the cost of
long-term stroke care.2 The gain of
additional QALY translates into cost
efectiveness which has been shown
across various countries and diferent
types of health and economic systems across the world. Given the fact
that clinical outcomes are strongly
dependent on time to recanalization
(removing the blood clot), it is important to examine the socioeconomic
disparity of geographic living distance
from thrombectomy capable stroke
centers as related to patient outcomes.
Currently, there is no literature comparing patient outcomes from thrombectomy to median income levels
and geographic living distance from
accredited thrombectomy capable
stroke hospitals. In this study we
performed a comprehensive literature review to understand the cost
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FIGURE: A. (left panel) Box and Whisker plot representing the difference in access
to thrombectomy capable stroke centers (TCCs) within one hour of travel time in high,
medium, and low-income states (the y-axis shows the percentage of the population
with one-hour access) The “x” within the box represents mean percent access, while
the upper and lower limits represent the interquartile range Note: the plot does not
include Alaska Since Alaska does not currently have a TCC and skewed the results
B. (right panel) Chart showing average median household income of states with high
(>50%) rate of access to low (<50%) rate of one-hour access to endovascular care
The Y-axis shows median household income in US dollars Comparison of the median
household income between states with high (>50%) and low (< 50%) one-hour access
to endovascular stroke centers had an average median household income of $65009
compared to $55683 (P < 0 001)
efectiveness of mechanical thrombectomy in a global context. We
additionally estimated timely access
(less than one hour) to thrombectomy
capable stroke centers (TCCs) and
evaluate the relationship of access
with socio-economic status using US
Census, median household income
and ambulance data. We further
demonstrate that timely access to
stroke care is imperative for optimal

outcomes, and such access varies by
socioeconomic geography. To help
improve stroke outcomes nationally
and standardize access to care, more
stroke centers could be developed
in geographical locations with lower
median income.
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ABBREVIATIONS:
Quality-adjusted life years (QALY),
t h rom b e c tomy ca pa ble st roke
centers (TCCs). United States of
America (USA), US Dollar(USD),
Solitaire With the Intention for
Thrombectomy as Prima r y
Endovascular Treatment for Acute
Ischemic Stroke (SWIFT PRIME),
H i g h l y Ef fe c t i ve Re p er f u sion
Evaluated in Multiple Endovascular
Stroke Trials (HERMES), Mechanical
Embolus Remova l i n C erebra l
Ischemia (MERCI), Mechanical
thrombectomy after intravenous
alteplase versus alteplase alone after
stroke (THRACE)

TABLE: Table Different studies showing Cost/QALY gained and data sources used

Country

Clinical trial used for
data source

Incremental Ratio
of endovascular
treatment (Cost /
QALY gained)

Kunz et al , 2016

USA

Hermes Collaboration,
meta-analysis
(Goyal et al )

$3110 (2016)

Shireman et al

USA

SWIFT PRIME

$4881 (USD 2015)

Leppert et al , 2015

USA

MR CLEAN

$14 137 (USD 2012)

Patil et al , 2009

USA

MERCI study

$12 120 (USD 2008)

Kim et al , 2011

USA

Multi-MERCI study

$16 001 (USD 2009)

Nguyen-Huynh et
al , 2011

USA

Multi-MERCI study

$9386 (USD 2009)

Achit et al , 2017

France

THRACE

€ 14,881

Kabore et al , 2019

France

SWIFT PRIME

€ 14,715

Bouvy et al , 2013

Netherlands

Expert panel opinion

€ 1922 (Euros 2010)

Ganesalingam et al ,
2015

United
Kingdom

Hermes Collaboration,
meta-analysis (Goyal
et al )

$11 651 (USD 2013)

Study
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The annual incidence of malignant
melanoma in South Africa is amongst
the highest rates in the world at 4.76
per 100,000 persons overall and up
to 19.2 per 100,000 in whites.1 While
South Africa has the highest number
of medical schools in Sub-Saharan
Africa, surgical training for dermatologists has historically been limited.
The Global Health Dermatologic
Surgery (GHDS) Training Program
was developed to provide dermatologic surgery curriculum and training
to the registrars (residents), and consultants (attending physicians), at the
Nelson Mandela School of Medicine
(NMSOM) in Durban, South Africa.
We conducted a prospective qualitative study of the 15 total training
trips from 2014–19. The Institutional
Review Board of the Nelson R.
Mandela School of Medicine at
the University of Kawzulu-Natal
approved this study. Patients were
screened for inclusion in this study by
local dermatologists and were scheduled for a procedure. Throughout the
program, the following were recorded
in a REDCap database: tracking
of type of procedures, postoperative complication rates (hematoma,
infection, dehiscence, pain, and serosanguinous discharge), and patient
satisfaction surveys. Surgeons phoned
patients if they did not show up for
follow-up. In addition, consultant/
registrar surgical knowledge was
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TABLE 1: Patient and Operative Characteristics at the Nelson Mandela Hospital,
2014–19
Characteristics

No.

%

Pre-operative Diagnosis

(n=362)

Keloid

86

23 76

BCC

78

21 55

Sebaceous cyst

24

6 63

Neurofbroma

19

5 25

Hydrocystoma

16

4 42

Dermoid cyst

16

4 42

Epidermoid Cyst

15

4 14

SCC

13

3 59

Other

74

20 44

Procedures

(n=387)

Excision
Simple Excision

286

73 90

Excisional Biopsy/Disc Excision

26

6 72

ED&C

7

1 81

Shave Excision

4

1 03

Excision & Injection, steroid

4

1 03

Biopsy

31

8 01

Shave biopsy

2

0 52

Punch Biopsy

1

0 26

Injection, steroid

3

0 78

Injection, bleomycin & Cryotherapy

1

0 26

Injection, 5FU

1

0 26

Other

21

5 43

Reconstruction

(n=147)

Biopsy

Injection

142

96 60

Flaps

6

4 08

Incorporated into other repair

3

2 04

Grafts

1

0 68

Primary Closure

assessed by pre- and post-didactic
assessments.
Seventeen volunteer surgeons
(four surgeons made multiple trips)
taught and super vised a total of
21 registrars and consultants over
the 15 trips between 2014–18. They

evaluated 362 patients and 387 procedures were performed. Of the 299
patients who followed-up at one
week, 236 (78.93%) had no complications at all. 30 (10.03%) patients had
reported infections of the surgical
site. Dehiscence of the surgical site
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TABLE 2: Complications and
satisfaction survey results of patients
who returned for one week follow up
Outcome

No. (%)

Complications

(n=299)

No Complications 236 (78 93)
Infection

30 (10 03)

Other

15 (5 02)

Dehiscence

12 (4 01)

Hematoma

5 (1 67)

Seroma

1 (0 33)

Satisfaction survey result
Site Appearance

(n=259)

“Very Satisfed” 123 (47 49)
“Satisfed” 113 (43 63)
“Indifferent,
No opinion”

17 (6 56)

“Not Satisfed”

6 (2 32)

Site Feel

(n=258)

“Very Satisfed” 115 (44 57)
“Satisfed” 124 (48 06)
“Indifferent, No opinion”

12 (4 65)

“Not Satisfed”

7 (2 71)

was noted in 12 (4.01%) patients and
hematomas reported in fve (1.67%)
patients. On a 1–4 scale, the mean
scores for both site appearance and
site feel was 3.37, indicating the most
patients were “satisfed” to “very satisfed” for their surgical site’s appearance and feel at 1-week post operation.
Dermatologic surgery knowledge and
competencies were assessed using a
40-point test. Consultants and registrars significantly improved their
scores on the post-didactic assessments; the diference in the posttest
scores was 23.4 points (p = .003, 95%
confdence interval 10.9, 35.9).
Short term dermatologic medical
ser vice trips, in which a visiting
dermatologist provides care to an
underserved group for a short period
of time, provide poor long-term outcomes and may not be cost-efective.2,3
However, long-term educational programs with a focused clinical scope
may establish cost-efective long term
means of improving care.4 The GHDS
training program shares goals with
other international medical missions,
such as providing robust cultural

and educational exchange, but with
the primary goal of long term selffulflling sustainable surgical training,
thereby establishing the NMSOM as
a training hub for sub-Saharan Africa
for future dermatologists.
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It was previously demonstrated that
health care professionals would like
additional education on medical cannabis.1 However, there has not yet
been a review of the status of medical
cannabis curriculum for allied health
care trainees worldwide. Given that
future health care workers will be
placed on the forefront of patient
care, they must be prepared to counsel
patients. This study was designed to
address this gap in knowledge.
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Methods: A search syntax was
medical and allied health students
generated and the PubMed, ERIC,
are not properly educated and knowlCINAHL, and Web of Science dataedgeable on this emerging field of
bases were searched for relevant
clinical care. The findings suggest
articles. A gray literature search of
that the implementation of compeGoogle Scholar, MedEd, Medline,
tency-based curricula on medical canand the Proquest Dissertations and
nabis is essential for allied health care
Theses section was
also performed. All
While the medical cannabis landscape is develtitles and abstracts
were screened.
oping, medical and allied health students are
S e l e c te d a r t ic l e s
were subsequently
screened using prenot properly educated and knowledgeable on
determined inclusion and exclusion
this emerging feld of clinical care.
criteria.
Result s: A l l ied
health care trainees lacked suffitrainees to have the appropriate level
cient knowledge about medical canof knowledge to counsel and educate
nabis and did not feel prepared to
their patients.
counsel patients on this subject.
REFERENCES
They expressed a growing interest in
1. Gardiner KM, Singleton JA, Sheridan
medical cannabis and would like more
J, Kyle GJ, Nissen LM. Health professtandardized education on the topic.
sional beliefs, knowledge, and concerns
Faculty and deans at various institusurrounding medicinal cannabis — A
tions agreed on the need to educate
systematic review. PloS ONE. 2019;14(5).
doi:10.1371/JOURNAL.PONE.0216556
students on the subject and aimed
to implement courses on medical
cannabis or expand their existing
curricula.
Conclusions: While the medical
cannabis landscape is developing,
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Homelessness presents significant
barriers to health care and is associated with increased hospitalizations.1
Interventions aimed at improving
care transitions and facilitating access
to stable housing are key to reducing
hospital visits and readmissions.2 The
state of homeless health care and its
associated costs are important areas
of public health research as these
investigations provide essential data
needed to motivate targeted interventions such as medical respite
programs.2 Here we present a systematic review of investigations into
the state of homeless health care,
focusing on risk factors for hospital
readmission, demographics, and the
most commonly used study designs.
All together, we aim to more clearly
defne a roadmap for future research.
Methods: The literature search

Risk Factors for Readmission

Sex

100
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•
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Discharge to Street
Cl High Discharge Acuity
Cl Seizure
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•
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=
•
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•
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11::::1
# prior admissions
Cl

•

Urban Environment

FIGURE 1: An overview of the results and characteristics of the literature review
performed
was carried out using standardized PRISMA criteria, using the
PubMed database and the MeSh
terms: “(Homeless Persons) AND
(Readmission).” The references of
retrieved articles were reviewed for
identifcation of additional relevant
studies. Primary inclusion criteria
were defined as the article investigating either homeless readmission
rate, causes of homeless readmission,
or risk factors for homeless readmission. Abstracts not meeting these

criteria were excluded. Article data
was then extracted, aggregated, and
analyzed. Statistical and numerical
analysis was performed in GraphPad
v8 statistical software package.
Results: The literature search
returned a total of 81 articles. As shown
in Figure 1.A, 33 articles were excluded.
Figure 1.B shows the majority of
articles (52%, n=25) were a retrospective cohort study. Other study designs
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included prospective cohort (18.7%,
n=9), randomized control trial (4.2%,
n=2), case control (4.2%, n=2), case
series (2.1%, n=1), and hybrid/combinatorial design (18.7%, n=9). A total
of 1,748,550 patients experiencing
homelessness were described amongst
the 48 articles. Figure 1.C summarizes
demographic data collected in this
study. Approximately 60% of that
cohort identifed as male with a mean
age of 39 years old. Race distribution
among the cohort was 38% Caucasian,
40% African American, 5% Asian, 4%
Native American, and 28% Hispanic.
Twenty broad themes of risk factors
[Figure 1.D] were identifed for patient
readmission, with the most commonly
mentioned risk factors being chronic
neuropsychiatric disease (mentioned
in 26% of 39 articles that analyzed
risk factors), illicit drug abuse disorder
(18%), and alcohol abuse disorder
(10%).
Discussion: Retrospective designs
were by far the most commonly used.
A 2017 systematic review tabulated
the ways in which numerous retrospective studies identifed homeless
patients by information found in
patient charts.3 Identifcation criteria
for homeless patients was widely heterogenous between studies and the
lack of reliable standardization was
noted to be a significant drawback
towards data interpretation across
multiple retrospective investigations.
Our fnding that retrospective designs
are most commonly used in the study
of homeless medicine highlights the
importance of implementing standardized homeless screening tools
in the hospital setting [Figure 2].
Fundamental to studying homeless
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Intervention:
Homeless Patient Identification/Screening

Randomized
Controlled Trial

Retrospective

EMRChart
Review

Pretest-Posttest
Control Group Trial

Database Cross-Referencing
w/ Medicaid Claims Data

Interventions:
Medical Respite Care,
Improve Care Transitions/ Coordination of Care

FIGURE 2:Study designs in homeless medicine and associated interventions
health care is the ability to reliably
identify homeless patients.4
Our review also revealed a new
methodology for investigating homeless health care.5 Racine et al. collected homeless person Medicaid
identifcation numbers from a nonproft database and matched the IDs
to the Massachusetts Medicaid claims
database. This revealed detailed
person-level homeless health care utilization information such as city-wide
hospitalizations, ED visits, expenditures, and diagnoses all without
relying on patient chart information.
Not all cities have access to similar
databases required to replicate these
analyses, but Homeless Management
Information Systems, which are
found more commonly, may prove to
be a useful tool for designing similar
database-matching investigations.
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Introduction: Explosions and bombings remain real threats that have the
capacity to quickly create thousands
of casualties with devastating injuries
(see Figure 1 a,b). Because of this, the
medical community needs to remain
ready to respond to these high-stress

FIGURE 1: Temporal (A) and geographic (B) distribution of bombings related to
terrorism from 2015–18

was to perform a literature review and
meta-analysis of all articles reporting
on blast injury trauma with the ultimate goal of ascertaining diferences
in injury profles reported between
Military and Civilian
casualties. Such data
... [T]he fatality rates from neurological
can be implemented
for disaster preparainjury are approximately equal; therefore,
tion a nd education
in medical facilities
the data suggest injuries sustained in the
worldwide.
Methods: The literat u re sea rch wa s
setting of helmet protection are more likely
designed and executed
(per PRISMA guideto be survivable.
l i n e s) t o c o m p a r e
blast injury patterns
events. To date, few articles have
between Military and Civilian casualsummarized key details of blast injury
ties following terrorist bombing. The
profles in terrorist bombings globally,
search was performed using selected
and no studies have analyzed the difMeSH search terms. Injury pattern
ference in blast injury profles between
data was extracted and stratifed into
Military and Civilian populations.
Abbreviated Injury Scale (AIS) body
1
Thus, the primary aim of this study
region numerical descriptors for the

head/neck (1,3), thorax (4), abdomen
(5), and extremities (7,8). Data means
were then calculated for each AISdefined region and then compared
between articles describing Military
populations versus those describing
Civilian populations. Statistical
analysis was performed in GraphPad
Prism v8 statistical software package
(San Diego, California). Data sets
were initially scrutinized for normality, then assessed for statistically
significant differences (defined as
alpha < 0.05) using Welch’s t-test of
unequal variance. Error within the
data sets were reported as a 95%
Confdence Interval (CI).
Results: The literature search
revealed a total of 806 articles (342
Military, 464 Civilian), with 28 (10
Military, 18 Civilian) meeting all
inclusion criteria. A total of 33,387
unique injuries were reported (n=18,711
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Military, n=14,676 Civilian) in these
articles. Figure 1 shows that there are
several diferences in injury patterns.
In both populations, AIS regions 7,8
were most afected by bombings, followed by AIS 1,3, AIS 5, then AIS 4.
In addition, there was a signifcant
diference between injuries reported
in AIS regions 1+3 reported between
the Military and Civilian populations (p=0.00632). There were also
marginally lower reports of thoracoabdominal injuries in the Military
population compared to Civilians,
but outliers in both data sets make
statistical conclusions difcult. There
were no significant differences in
victim age, reports of limb injuries, or
proportion of instantaneous fatalities
in either population.
Conclusions: Given that Military
members typically wear protective
body armor and ballistic helmets
when exposed to a blast, it was unexpected to see a higher number of head
and neck injuries. Even though there
are increased reports of head and
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FIGURE 2: Blast injury patterns and differences between Military and Civilian
personnel

neck injuries, the fatality rates from
neurological injury are approximately
equal; therefore, the data suggest
injuries sustained in the setting of
helmet protection are more likely
to be sur vivable. Ultimately this
implies that in a given blast MCI,
the Militar y Treatment Facility
receiving casualties might actually see
a higher number of patients with blast
neurotrauma compared to Civilian
hospitals. Though this hypothesis
requires further investigation, this
fnding emphasizes the importance

of neurotrauma stabilization and the
importance of intimate integration
of the neurosurgical service in the
preparation and response phases of
mass casualty scenarios related to
terrorism bombings.
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Access to medical cannabis products
(MCPs) has rapidly increased due
to changing regulatory landscapes.1
However, literature on consumer
behaviors and attitudes with regards to
dermatologic use is limited, and therefore we sought to address this gap.2
Methods: A survey was emailed via
SurveyMonkey’s platform to users 18
and older of their rewards panel asking
about usage patterns and beliefs
regarding MCP use to treat dermatologic conditions.
Results: 504 adults completed our
survey (92.1% response rate) with a
relatively consistent distribution of
age and gender. 17.6% of respondents
used an over-the-counter (OTC) cannabis product without dermatologist
recommendation (NROTC: non-recommended, over-the-counter) to treat
a skin condition. The most common
indications were acne (28.4%), psoriasis (26.1%) and atopic dermatitis
(22.7%) (Figure) and the most common
route of administration (ROA) was
topical (64.7%). Of those who had seen
a dermatologist (66.3%), 15.3% used
an OTC product per their dermatologist’s recommendation (DROTC:
dermatologist recommended, overthe-counter), most commonly for

■

DRCR {n-25)

DROTC (n-50)

D NROTC (n"-88),

FIGURE: Self-reported reasons for using cannabis products Respondents who
indicated they had used a DRCR (n=25), DROTC (n=50), or NROTC (n=88) cannabis
product for a dermatologic indication were asked to indicate from a list of choices what
indication they had used the product for Respondents in the DRCR and DROTC groups
were only given the option to answer only if they had seen a dermatologist, were
recommended these products by the dermatologist, and they respondent subsequently
used the product Values are reported as percentage of respondents who selected an
answer Respondents were allowed to select more than one option
psoriasis (32%), rosacea (30%), and
acne (30%) (Figure) and the most
common ROA was topical (62.5%).
7.8% of those who had seen a dermatologist used an MCP which required
a Department of Health-approved
card per their dermatologist’s recommendation (DRCR: dermatologist
recommended, card requiring), most
commonly for acne (68%), psoriasis
(28%), and rosacea (28%) (Figure) and
the most common ROA was ingestion
(50%) per their dermatologist’s recommendations. 11.8% of respondents
were not comfortable seeing a dermatologist who recommended MCPs and
6.4% of respondents disapproved the
use of cannabinoids for dermatologic
indications.
Conclusion: This survey shows that
consumers use cannabis products for
numerous dermatologic conditions.

Inf lammator y disorders such as
acne, psoriasis, atopic dermatitis, and
rosacea were among some of the conditions being most frequently treated
by cannabis products. It is important
to note that current literature on the
subject is limited, and the benefits
and risks of use are not well understood. Physicians should be aware of
common barriers to initiating treatment with MCPs, such as skepticism
and poor understanding, as well as cost
and legality issues. Given the interest
in medical cannabis for dermatologic
use as shown by this study, it is important for dermatologists to stay up to
date with the scientifc and legal landscapes in order to best serve patient
needs. It is important to understand
and inform patients who may seek out
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cannabis products that recognized,
evidence-based treatments currently
remain the standard of care, though
MCPs may be a suitable option for

patients who are interested in alternative therapies.
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Reasons for Initiatinga TelehealthAppointment

The COVID-19 pandemic has drastically changed the practice of dermatology as social distancing guidelines
have led to a shift from in-ofce care to
virtual telehealth (teledermatology).1
We aimed to determine patient satisfaction, perceived barriers, as well
as indications for teledermatology
appointments during the COVID-19
pandemic.
Methods: A survey was sent out
via Sur veyMonkey’s online platform to the George Washington
University Medical Faculty Associates’
Department of Dermatology patients
who were 18 years and older and
attended telehealth appointments
during the COVID-19 pandemic.
Results: Out of 894 invitations
sent, 168 patients completed our
survey (18.8% response rate). The
most common reasons for making a
telehealth appointment were for a new
rash (11.6%), eczema (9.8%), and psoriasis (9.1%) (Figure). The most common
reasons respondents liked telehealth
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FIGURE: Pie chart indicating reasons for patients’ telehealth appointment N=168
Respondents were only allowed to select one answer from a dropdown menu
were because of time efciency (81.1%),
not requiring transportation (74.2%),
and maintaining social distancing
(73.6%). The most common reasons
respondents did not like telehealth
were due to lack of physical touch
(26.8%) and feeling they received an
inadequate assessment (15.7%). Very
few patients reported that they were
unlikely to undertake another telehealth visit (9.94%) or recommend a
telehealth visit to others (6.92%).
Conclusion: As the COVID-19
pandemic continues to afect millions
of patients who require dermatology
care, telehealth proves to be an efective and useful modality to bring care
to patients during this public health
emergency. The majority of patients
who had telehealth encounters with
our dermatology department found
a telehealth visit to be an adequate
substitute for an in-person visit. Major

reported drawbacks include patients
feeling like they did not receive an
adequate examination or did not have
any physician touch though these were
still reported in a minority of patients.
Overall, the convenience and efcacy
of telehealth as well as its ability to
maintain separation while social distancing recommendations are in place
make it an efective way for dermatologists to continue to provide quality
and safe care during the pandemic as
well as during potential future public
health crises.
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Predicting Deletion of Chromosomal Arms 1p/19q in
Low-Grade Gliomas from MR Images Using Machine Intelligence
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Several studies have linked co-deletion of chromosome arms 1p/19q in
low-grade gliomas (LGG) with positive response to treatment and longer
progression-free survival. Hence,
predicting 1p/19q status is crucial for
efective treatment planning of LGG.
In this study, we predict the 1p/19q
status from MR images using convolutional neural networks (CNN), which
could be a non-invasive alternative to
surgical biopsy and histopathological
analysis. Our method consists of three
main steps: image registration, tumor
segmentation, and classification
Continued on p. 34

FIGURE 1: An example of low-grade glioma with and without 1p/19q

codeletion. Images a and b show T2 and post contrast T1 for non-deleted
1p/19q. Images c and d show T2 and post contrast T1 for codeletied 1p/19q.
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FIGURE 2: A fowchart of the multi-scale CNN archetecture Blue box is the input image Yellow boxes are convolutional layers Green
boxes are rectifed linear unitys (RELU), activations Red Boxes are max pooling layers Purple boxes are fully connected layers, plus a
softmax binary classifer Cyan circle shows the output label
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Continued fom p. 33
of 1p/19q status using CNN. We
included a total of 159 LGG with three
image slices each who had biopsyproven 1p/19q status (57 non-deleted
and 102 co-deleted) and preoperative
postcontrast-T1 (T1C) and T2 images.
We divided our data into training,
validation, and test sets. The training
data was balanced for equal class probability and was then augmented with
iterations of random translational
shift, rotation, and horizontal and

vertical fips to increase the size of
the training set. We shufed and augmented the training data to counter
overfitting in each epoch. Finally,
we evaluated several confgurations
of a multi-scale CNN architecture
until training and validation accuracies became consistent. The results
of the best performing confguration
on the unseen test set were 93.3%
(sensitivity), 82.22% (specifcity), and
87.7% (accuracy). Multi-scale CNN
with their self-learning capability provides promising results for predicting

1p/19q status non-invasively based
on T1C and T2 images. Predicting
1p/19q status non-invasively from MR
images would allow selecting efective
treatment strategies for LGG patients
without the need for surgical biopsy.1
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Malignant Pineal Parenchymal Tumors in Adults:
A National Cancer Database Analysis
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In the absence of randomized trials
for adult pineal parenchymal tumors
(PPT), we use a national database to
evaluate treatment trends and the
survival impact of surgery, radiation,
and chemotherapy.
Methods: The National Cancer
Database was queried for adult
patients with histologically confrmed
PPT diagnosed from 2004 to 2016.
Univariate and multivariate Cox
regressions were used to evaluate
the prognostic impact of covariates.
K a pl a n -Meier s u r v i v a l c u r ves
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PB

PPTID
Histology

FIGURE 1: Stacked Bar Graph of Treatment Trends for PB and PPTID PB is most
commonly treated with surgery and adjuvant chemoradiation PPTID is most commonly
treated with surgery alone or with surgery and adjuvant radiation

were generated for comparative
subanalyses.
Results: A total of 202 patients
met inclusion criteria. A plurality
of pineoblastoma ( PB) patients
were treated with trimodal therapy
(43.6%, 24/55) ( Fig ure 1). Pinea l
parenchymal tumor of intermediate
differentiation (PPTID) patients
were most commonly treated with
either surgery alone (35.1%, 47/134)
or with surgery and radiation (32.8%,

44/134) (Figure 1). Factors associated
with improved overall survival on
mu ltiva riable a na lysis included
younger patient age, female sex, lower
comorbidity score, receipt of surgery,
and receipt of radiation (each p < .05).
Receipt of chemotherapy was not
associated with survival. Subanalyses
revealed that the efect of radiation
on survival was most prominent in
PB patients and in PPTID patients
w ho h ad not recei ved su rger y
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(Figure 2). No survival benefit of
adjuvant radiation was demonstrated
in surgically treated PPTID patients
(Figure 2).
Conclusions: Currently, there is a
paucity of data regarding treatment
outcomes for adult PPT tumors, and
this is the largest study to date. 1,2
While radiotherapy and surgery were
found to increase survival in all PPT
patients, there was no survival beneft
of adjuvant radiation in surgically
treated PP TID. T h is su g gests
overtreatment of many PPTID adult
patients with radiotherapy.
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Impact of Varian Histology on Occult Nodal Metastasis after
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer:
A Review of the National Cancer Database
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Variant histology accounts for 30%
of bladder urothelial carcinoma
cases. Variant histology is associated
with a higher incidence of locally
advanced disease and occult regional
lymph node metastasis.1 Neoadjuvant
chemotherapy (NAC) is the goldstandard treatment for resectable
cT2-4 disease as it achieves pathologic
complete response in select patients
at the time of radical cystectomy
(RC). Post-hoc analysis of a landmark
randomized trial has demonstrated
preserved chemosensitivity and even
pT0 status in the setting of variant histology. While there is much interest
in the role of bladder preservation
for such patients, the observation
of pT0N+ pathology in patients who
undergo subsequent RC has prompted
concerns about this approach.2 The
aim of this study is to analyze how
variant histology impacts pathologic
downstaging after NAC.
A retrospective cohort analysis of
5,335 cT2-4N0M0 patients who underwent NAC and RC between 2004
and 2016 was performed using the
National Cancer Database (NCDB).
These patients were stratified by
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FIGURE: Kaplan-Meier Curve of Pure UCC and Variant Histology Types

histological type into pure urothelial
of 48.8% compa red to 38.5% in
cell carcinoma (UCC) and variant
the variant group (p<0.001). After
groups (i.e. neuroendocrine, microadjusting, UCC was associated with
papillar y, squamous, etc.) using
significantly decreased mortality
the WHO ICD-O classification.
hazard relative to variant histology
The rate of pathologic
downstaging to ≤pT1
Our study showed that the propensity for
was analyzed, along with
concomitant persistent
pN+ status. Overall surdistant spread contributed to signifcantly
vival was analyzed using
Kaplan-Meier estimaworse survival outcomes in the variant
tion and multivariable
Cox-proportional hazhistology group.
ards regression, stratified by histology type.
(a HR= 0.75; p<0.001). UCC had
Multivariable models were adjusted
lower adjusted odds of being pN+
for confounding demographic and
(aOR=0.60, p<0.001), specifically
clinicopathologic variables.
pN2 (aOR=0.57) and pN3 (aOR=0.40).
Of the cases, 7.9% were variant
Node-positive variant histolog y
histolog y while 92.1% were pure
patients demonstrated higher node
UCC. Pure UCC was associated
positive count compared to pure UCC
with signifcantly better unadjusted
(median 3 vs 2 nodes, p<0.001).
survival with a 5-year survival rate
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O u r st ud y showed t h at t he
prop en sit y f or d i st a nt spr e a d
contributed to significantly worse
sur vival outcomes in the variant
histology group. Patients with variant
histology were more likely to harbor
occult regional lymph node metastasis
in the setting of intravesical pathologic
complete response (pT0). Although
micropapillary histology was more
likely to be downstaged to pT0,
the increased likelihood of residual
nodal disease reinforces the role of
surgical consolidation after NAC for
these patients. On the other hand,
neuroendocrine histology may allow
for successful bladder preservation
a f te r c h e m ot h e r a p y g i v e n it s
higher downstaging to pT0N0. RC
with thorough pelvic lymph node
dissection remains the gold-standard
for surgical consolidation after NAC,
especially in cases of variant histology.
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TABLE:
Outcome
Path Node Status
0
l
2
3
Path Node+
Downstage to pT0
Complete
Downstage to
pT0N0
Partial downstage to
12Ii~.
12IapTI
Any PI.downstage
Downstage pT0Nl-3

Mixed Histology
(n=419)

PureUCC
(n=4916)

Adjusted Odds Ratio
(95%

311 (74.2%)
36 (8.6%)
55 (13.l %)
17(4.1%)
108 (25.8%)
I JO (26.3%)
104 (24.8%)

4030 {82.0%)
366 (7.5%)
426 (8.7%)
94 (1.9%)
886 (18.0%)
1269 (25.8%)
1235 (25.1%)

Reference
0.75 (0.51 - l.l l)
0.57 (0.41 - 0.79)
0.40 (0.23 - 0.70)
0.60 (0.47 - 0.77)
0.99 (0.75 - 1.31)
1.04 (0. 78 - 1.38)

0.146
<0.001
0.001
<0.001
0.948
0.815

45 (10.7%)

689 (14.0%)

1.25 (0.89 - 1.75)

0.192

155 (37.0%)
6 (1.4%)

1958 (39.8%)
34 (0.7%)

1.13 (0.89 - 1.44)
0.53 (0.20 - 1.37)

0.317
0.190
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Evaluation of Selective HDAC6 Inhibition as a
Potentiator of Antigen-Targeted Immunotherapy in
Diffuse Large B-Cell Lymphoma
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Patients with aggressive difuse large
B-cell lymphoma (DLBCL) who fail
initial combination therapy, may
undergo second-line treatment with
curative intent; however, treatment
involves high-dose chemotherapy and
autologous stem cell transplantation,
which is reserved only for eligible
candidates.1 One-third of candidates
will proceed with high-dose therapy
with durable remission rates limited
to approximately 25%.1
Clearly, there exists a population
of patients in need of new treatments.
Hope may be found in anti-CD19
chimeric antigen receptor (CAR)
T-cell therapy, which has garnered
wide success in the treatment of
pre-B-cell acute lymphoblastic leukemia (ALL).2,3 Although CAR T-cell
therapy has not had the same level of
success in DLBCL, results remain
encouraging and demonstrate a need
for further research. Additionally,
clinical studies of bispecific antiCD19xCD3 or a nti- CD20xCD3
monoclonal antibodies have shown
similar promise.4
Despite the excitement surrounding antigen-targeted immunotherapies, these novel treatments face
critical obstacles. Patients receiving
CAR T-cell therapy or bispecific
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FIGURE 1:
monoclonal antibodies might only
beneft from brief remissions or may
never enter remission at all. 2,3 Similar
to existing treatments, CAR T-cell
therapy is challenged by resistance
and failure of long-term disease
remission.2,3
One reason may be antigen loss.
Several studies have demonstrated the
generation of escape variants lacking

the targeted CD19 or CD20 antigens
when under the selective pressure of
immunotherapy. A theorized mechanism for this is interrupted protein
translocation, supported by observations of CD20 trafcking disruption
in rituximab-resistant B-cell cancers.4
Histone deacetylase 6 inhibitors
(HDAC6i) have been well characterized as modulators of protein
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trafcking and have been shown to
upregulate the expression of CD20 on
B-cell tumor lines.4,5 Achieving a similar efect with CD19 expression may
ofer a new avenue for potentiating
anti-CD19 CAR T-cell platforms,
particularly because immunotherapy
studies have shown that only a small
diminution of surface antigen may be
sufcient for treatment failure.3
Through our studies, we investigated the efect of HDAC6i on surface expression of CD19 and CD20
in rituximab-resistant (CD20-low)
Raji4RH cells. Raji4RH cells were
treated with either 50 ng/mL IL-4,
5µM of the HDAC6i, Nexturastat
A (NextA), or a combination thereof
for 48 hours. Untreated Raji4RH cells
and untreated Raji cells (CD20-high)
were used as controls. HDAC6i in
combination with IL-4 increased
CD20 expression in rituximab-resistant Raji4RH cells (Figure 1a). Later,
at concentrations of 10µM, HDAC6i
achieve a 2-fold increase in CD20 surface expression as reported by median
fuorescence intensity compared to
the untreated control (Figure 1b).
Next, rituximab-resistant Raji4RH
cells were treated with 50 ng/mL IL-4
and increasing doses of NextA for 24
hours. (Figure 2). When examining
mean CD19 fuorescence, we observed
an increase, although modest, in
CD19 surface expression at 1-hour and
6-hours post-treatment.
O u r r e s u lt s e s t a b l i s h t h a t
HDAC6is can increase CD20 expression in CD20-low B-cells and suggest
a strong potential for HDAC6i to
function as a positive modulator of
CD20 expression in the setting of
resistant disease. Additionally, our
studies suggest that there exists an
interaction between HDAC6 function and CD19 surface expression.
These results are promising as even
slight changes in surface expression of
antigen targets can greatly infuence
immunotherapy response. However,
further optimization of treatment
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FIGURE 3:
dosing and cytokine combination is
necessary, warranting the need for
future studies.
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Adenocarcinoma of the bladder is an
especially rare histological subtype
of bladder neoplasms, accounting for
approximately 0.5-2% of diagnoses
in the United States.1 These tumors
can be further classified based on
origin from the urachus, an embryologic structure that functions to
connect the developing bladder to
the allantois. In up to one-third of
individuals, remnants of these developmental tissues may persist and serve
as a potential location for malignancy.
Importantly, there is little consistent
evidence regarding the treatment
of both non-urachal and urachal
adenocarcinomas.2 Although radical
cystectomy (RC) is often considered
the standard of care for both locally
advanced urachal and non-urachal
adenocarcinomas, there is a paucity
of data providing conclusive guidance
regarding any additional management
options that may be of beneft in such
an uncommon histological bladder
neoplasm.3 Specifcally, the relatively
poor prognosis associated with locally
advanced bladder adenocarcinoma
necessitates investigation of the utility
of adjuvant chemotherapy (AC) and
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or pT(any)Nl-3 bladder adenocarcinoma
from NCDB 2010-2016 (n=330)

Adjuvant chemotherapy
(n=79)

No adjuvant chemotherapy
(n=251)

Comparison #1: Radical (n=56) vs.
Partial Cystectomy (n=23) (RC vs PC)

Comparison #2: Urachal (n=l0) vs.
Non-Urachal Subtype (n=69)

FIGURE:Methofological breakdowns
risk stratifcation of those who would
beneft from such systemic therapy.
This study seeks to evaluate the oncologic and surgical outcomes of those
with locally advanced disease treated
with and without AC.
Methods: A retrospective cohort
analysis was performed using the
National Cancer Database from 2006
to 2016. Patients with non-metastatic
locally advanced pT3-4 or pT(any)N1-3
primary bladder adenocarcinoma who
received AC only or did not receive
AC after radical or partial cystectomy
(PC) were included. The AC cohort
was further sub-stratifed by surgery
type (PC versus RC) and disease
origin (urachal versus non-urachal
subtypes) (Figure). Survival, oncologic,
and surgical outcomes were compared
between cohorts.
Results: Inclusion criteria identifed
79 AC patients and 251 no AC patients.
Of the 79 patients who received AC,

23 had PC procedure, 56 had RC procedure, 10 had urachal origin and 69
had non-urachal origin. Receipt of AC
was signifcantly higher in RC relative to PC (27.6% vs 18.1%; p = 0.049).
Urachal vs. non-urachal subtype did
not impact receipt of AC (25.3% vs
17.5%; p = 0.214), but urachal subtype
was associated with improved overall
survival compared to non-urachal
(47% vs 18%; HR = 0.37; p = 0.04).
Although receipt of AC was signifcantly associated with higher odds of
positive margins (46% vs 23%; odds
ratio = 2.85; p < 0.01), no diference in
overall survival was detected between
the AC and no AC cohorts (23% vs
19%; hazards ratio [HR] = 0.98; p =
0.91). Of note, independent of AC, PC
was associated with improved survival
compared to RC (51% vs 12%; HR =
0.25; p < 0.01).
Conclusions: There is no detected
sur viva l benef it to the use of a

Fusion | 2021

non-standardized AC regimen in
locally advanced bladder adenocarcinoma. Within the AC treated population, survival outcomes suggest that
urachal subtype may confer survival
advantage and that those patients
selected for PC tend to have improved
sur viva l. A lthough employing a
national dataset, statistical power was
limited given the rarity of this disease.

Further investigation is warranted on
a larger scale in order to assess the
impact of AC regimen, aford proper
patient selection, and enhance risk
stratifcation for oncologic outcomes.

2. Gopalan A, Sharp DS, Fine SW, Tickoo SK,
Herr HW, et al. (2009). Urachal carcinoma:
a clinicopathologic analysis of 24 cases
with outcome correlation. The American
journal of surgical pathology, 33(5), 659.
3.
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Comparison of Perioperative Characteristics and Outcomes
for Minimally Invasive vs Open Retroperitoneal Lymph Node
Dissection for the Treatment of Testicular Cancer: A NSQIP Analysis
Michael Wynne,
MSII
ADVISORS:
Andrew D
Sparks,1,2 , Michael
J Whalen1,2
1 Department of Urology, George
Washington University (GW)Hospital
2 The GW Medical Faculty Associates
Testicular cancer is the most common
solid tumor in young men ages 20 to
34 years old.1 Primary retroperitoneal
lymph node dissection (RPLND)
is an established post-orchiectomy
treatment option for men with clinical
stage I and IIA/B non-seminomatous
germ cell tumors (NSGCTs).1,2 Open
RPLND is currently considered
the gold standard approach for low
stage NSGCT; however, it is a major
abdominal procedure associated with
signifcant morbidity and prolonged
hospital stays.3,4 A minimally invasive surgical (MIS) approach seeks
to aford patients similar oncologic
outcomes with decreased morbidity.
Outcomes in robotic and laparoscopic RPLND for the management
of NSGCT have been studied in
recent case series, however limited
data currently exists directly comparing outcomes in MIS versus open
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FIGURE: RPLND Procedures by Year
RPLND. As such, the present study
queries the National Surgical Quality
Improvement Program (NSQIP)
database to assess 30-day perioperative outcomes and characteristics for
MIS vs open RPLND along with
trends over time.
The NSQIP database (2005–18)
was queried for patients with nondisseminated testicular cancer ±
retroperitoneal lymph node involvement. Patients with distant metastasis, a history of chemotherapy, or
a history of radiation therapy were
excluded. Chi-square, Fisher’s exact
test, independent samples t-test, and
Mann-Whitney U test were used to
identify unadjusted associations and
potential confounding covariates.

Multivariable logistic regression
and multivariable generalized linear
models were used to analyze independent associations between treatment
approach and perioperative outcomes.
Trends over time were analyzed by
way of Spearman’s rank correlation
coefcient analysis, ρ. All statistical
analysis was performed using SAS
version 9.4 (SAS Institute Inc., Cary,
NC) with a two-sided p-value < 0.05
considered statistically signifcant.
Inclusion criteria identifed 646
patients; 337 (52.2%) with MIS treatment and 309 (47.8%) with open
treatment. Compared to open, MIS
RPLND was signifcantly associated
Continued on p. 42
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TABLE: Multivariable Analysis for Perioperative Outcomes
30-Day Outcome

Open
(n=309)

MIS
(n=337)

Unadjusted
p-value

aOR
(95% CI)
or β (SE)

Multivariable
p-value

Superfcial SSI

4 (1 3%)

2 (0 6%)

0 433

0 87
(0 12 – 6 34)

0 89

Bleeding Transfusion

23 (7 4%)

13 (3 9%)

0 047

1 19
(0 54 – 2 62)

0 672

Mortality

—

3 (0 9%)

0 25

NE

—

Return to OR

5 (1 6%)

9 (2 7%)

0 359

1 07
(0 28 – 4 12)

0 927

Acute Care Stay >30 day

—

1 (0 3%)

0 999

NE

—

Reoperation

4 (1 3%)

6 (1 8%)

0 754

0 96
(0 19 – 4 69)

0 955

Readmission

18 (5 8%)

20 (5 9%)

0 953

0 96
(0 44 – 2 14)

0 928

C Diffcile

1 (0 3%)

3 (0 9%)

0 625

NE

—

Operative Time Mean ± SD

274 ± 124

147 ± 118

<0 001

-35 (9)

<0 001

Length of Hospital Stay
Median (Q1, Q3)

4 (3, 6)

1 (0, 5)

<0 001

-0 41 (0 07)*

<0 001

aOR=adjusted odds ratio for MIS vs open; CI=confdence interval; β=parameter estimate; SE=standard error; OR=operating room;
SSI=surgical site infection; NE=not estimable due to too few events; SD=standard deviation; Q1=frst quartile; Q3=third quartile; * β
(SE) natural logarithm transformed for nonparametric distribution before reverse transform for interpretation
Continued fom p. 41

with older age, non-White race,
diabetes, hypertension, weight loss
>10% 6 months prior to surgery, and
lymph node involvement (all respective p<0.05). There was a trend level
association between MIS RPLND
and a higher proportion of chronic
steroid use, pre-operative transfusion, and higher American Society of
Anesthesiologists (ASA) classifcation
(all respective p<0.1). Multivariable
analysis detected no signifcant difference in rates of superfcial surgical
site infection, 30-day mortality,
unplanned return to OR, acute care
stay > 30 days, reoperation, readmission, or C. Difficile complications. MIS RPLND was signifcantly
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associated with 35 ± 9 minute shorter
adjusted operative time and 51% ± 7%
shorter adjusted hospital stay (respective p<0.05) (Table). RPLND volume
has increased since 2005 (ρ= 0.724;
p=0.003) with the open approach
being utilized more often in recent
years (ρ= 0.101; p=0.013) (Figure).
MIS RPLND demonstrated comparable perioperative outcomes to
open RPLND with decreased length
of hospital stay, despite higher burden
of comorbidities. Although lymph
node yield could not be assessed within
the limitations of NSQIP, the shorter
operative time of MIS reinforces the
importance of thorough dissection
and adherence to template-based or
full bilateral dissection as indicated,
regardless of the surgical modality.
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Robotic-Assisted Laparoscopic Approach to Radical
Cystectomy Mitigates Surgical Complications in
Patients with Preoperative Malnutrition
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There is growing evidence of the
adverse impact of preoperative
malnutrition and hypoalbuminemia
on perioperative and postoperative
complications following radica l
cystectomy (RC) for the treatment
of muscle-invasive bladder cancer.
A robotic-assisted lapa roscopic
approach to RC is becoming more
widely used and, based on its reduced
per ioperative morbid it y, cou ld
potentially be a preferable surgical
modality for patients with nutritional
deficits. Prior studies examining
the i mpact of ma l nutr ition on
outcomes after RC have not explored
the influence of surgical modality.
This investigation will evaluate
the associations of robot-assisted
surgical approach with perioperative
and 30 -day postoperative
complications after RC. It will also
evaluate the efects of preoperative
malnutrition and hypoalbuminemia
on per ioperative a nd 30 - day
postoperative complications after
RC in the study cohort.
Methods: Retrospective review of
the American College of Surgeons

(ACS) National Quality Improvement
likely to be older, female, current
Database (NSQIP) identifed patients
smokers, have COPD and higher
who underwent RC with postoperaAmerican Society of Anesthesiology
tive diagnosis of bladder cancer and
(ASA) score. Regarding perioperative
1,2
non-disseminated disease (2005–18).
complications, malnourishment was
Surgical approach was categorized as
associated with greater preoperative
open vs. robotic/laparoscopic. Given
transfusions, systemic sepsis, peri/
there is not a universally accepted
postoperative bleeding transfusions,
defnition of “malnutrition” we ana30-day mortality, postoperative C.
lyzed the data in multiple ways to
difcile infection rate, and hospital
explore our hypotheses. The analysis
length of stay — despite actually
was performed using a composite
shorter operative time. In nongroup (low serum albumin (<3.5g/dL),
ma l nourished patients: robotic
10% 6-month preoperative weight
a pproach w a s a ss o ci ated w it h
loss, or BMI <18.5 kg/m2) as well as a
lower adjusted odds of bleeding
separate analysis for hypoalbumintransfusion (aOR=0.39), return to
emia only and there was not a sigOR (aOR=0.55), and fewer adjusted
nifcant diference in
outcomes. Therefore,
The typical benefts seen with robotic surgery
for this investigation,
malnourishment
translate to malnourished patients, although
was defned as either
h a v i n g low s er u m
albumin (<3.5g/dL),
they are still prone to longer hospital stay than
10% 6-month preoperative weight loss,
their adequately nourished counterparts.
or BMI <18.5 kg/m2.
Multivariable logistic
days from operation to discharge
regression and generalized linear
models were used for categorical and
(β[SE]= -1.3[0.3]) compared to open (all
continuous outcomes, respectively, to
respective p<0.05). In malnourished
patients: robotic approach was
characterize the association between
associated with lower adjusted odds of
robotic-assisted surgical approach and
bleeding transfusions (aOR=0.51) and
30-day perioperative/postoperative
complications following RC comfewer adjusted days from operation to
pared to non-robotic operations.
discharge (β[SE]= -5.2[1.1]) compared
to open (all respective p<0.05).
Results: Of 7,974 patients identifed,
Conclusions: Robotic-laparoscopic
730 (9.3%) were robotic-laparoscopic
approach to RC mitigated two of
and 7235 (90.7%) were open. There
were 1370 (17.2%) ma lnourished
the postoperative complications
patients a nd 6604 (82.8%) nona s s o ci ated w it h m a l nut r it ion :
malnourished. In the 739 robotic
bleeding transfusions and days from
cases, 102 (13.8%) were malnourished.
Continued on p. 44
Malnourished patients were more
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Continued fom p. 43
operation to discharge. The typical
benefits seen with robotic surgery
translate to malnourished patients,
although they are still prone to longer
hospital stay than their adequately
nourished counterparts. Further
improvements in per ioperative
pathways are needed to optimize
the experience of malnourished

patients u ndergoi ng rad ica l
cystectomy, especially given the
observed association with other high
risk comorbidities. These findings
highlight the fact that a robotic
approach to RC may be preferable for
patients with preoperative nutritional
defcits.
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Vascular rings are rare congenital
anomalies of the aortic arch which
result from inappropriate embryologic regression of the paired branchial arches. The term “vascular ring”
indicates vascular anomalies that
encircle the intrathoracic portion of
the esophagus and trachea.1 Vascular
rings can cause respiratory or gastrointestinal symptoms due to compression of these structures, which are
expected to improve with surgical
division. Advances in imaging technology have resulted in early detection
in asymptomatic patients. This poses
new challenges for management of
patients with known vascular rings.
We sought to analyze the presence
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Figure 1: Stratification of DAA and RAA patients by symptom severity

FIGURE 1: Stratifcation of DAA and RAA patients by symptom severity
and patterns of symptoms associated
with vascular rings, including severity
and time to symptom onset from
birth, and to determine predictors
of symptom resolution after surgery.
Methods: Single-center, 10-year
retrospective review of all patients
diagnosed with isolated vascular
rings between Januar y 2010 and
December 2019. Vascular rings were
classifed as either double aortic arch
(DAA) or right aortic arch with left
ligamentum arteriosum (RALL) by

echocardiography. Respiratory and
GI symptoms were examined for
their possible infuence on surgical
intervention and stratified using a
severity score.
Results: One hundred patients
with isolated complete vascular ring
met inclusion criteria. Thirty-four
patients (34%) had a DAA and sixtysix (66%) had RALL. Seventy-five
patients (75%) were diagnosed after
presenting with respiratory or gastrointestinal symptoms; twenty-fve
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(25%) were asymptomatic at presentation, diagnosed incidentally.
Symptoms were stratifed by severity
(Figure 1) and respiratory symptoms
were found to be more frequent,
regardless of arch anatomy.
Seventy-four patients (74%) underwent surgical division of the vascular
ring, out of which 99% (73/74) were
symptomatic. Forty-two patients
(63%) with RALL (n=42) received
surgical intervention compared to
thirty-two patients (94%) with DAA.
Chi-square analysis found moderate/
severe respiratory symptoms predictive of surgery in patients with
a RALL (OR 6.0, p = 0.002). At a
median follow-up of 2.2 years, incidence of overall symptoms decreased
signifcantly in patients who underwent surgical division (p<0.001); only
28 patients (39%) exhibited persistent
symptoms. The incidence of respiratory symptoms, including stridor and
recurrent respiratory infections, as
well as GI symptoms, decreased signifcantly in the postoperative period
(p<0.001). There was no change in
the incidence of asthma symptoms in
patients undergoing surgical intervention (p=0.808). Neither age at operation (p=0.158) nor the anatomic type
of the ring (p=0.332) were predictive
of symptom resolution. The presence

B)RAA-LLA

A)DAA

FIGURE 2: Volume rendering of contrast-enhanced CTA in a A) 2-month-old with DAA
from a posterior view, and a B) 3-year-old with RAA-AbSA and diverticulum of Kommerell
Both demonstrate compression of the trachea (yellow)
of airway narrowing on pre-operative
bronchoscopy or computed tomography resolved signifcantly postoperatively (62%, p<0.001). Incidence of
recurrent respiratory infections was
higher in the patients with residual
tracheal narrowing after surgical division (3/20 vs 0/54;p=0.02). Survival was
100% (74/74).
Conclusions: Surgical division of
the vascular ring leads to resolution
of obstructive symptoms in the vast
majority of patients, with the exception of symptoms of asthma. Patients
with symptomatic isolated vascular
rings should be ofered surgical intervention; those who present predominantly with symptoms of asthma may
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not beneft from surgery. Although
RALL is more common than DAA,
the latter are more likely to undergo
surgical intervention regardless of
symptom severity. Presence of postoperative residual tracheal narrowing
predicts a persistence of respiratory tract infections, but not other
symptoms. A coordinated multidisciplinary investigation of obstructive
respiratory and gastrointestinal symptoms is necessary for early diagnosis of
vascular rings and appropriate referral
for surgical intervention.
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Heterotaxy syndrome may be defned
as a spectrum of abnormally discordant organ situs resulting from aberrant left-right axis determination in
the thoracic and abdominal cavities.1
The abnormal degree of thoracic
and abdominal visceral symmetry is
associated with complex intracardiac
abnormalities, which may require
cardiovascular surgery early in life. We
sought to analyze outcomes of patients
with heterotaxy syndrome undergoing
cardiovascular surgical repair, with a
focus on univentricular palliation vs
full biventricular repair, and to determine predictors of mortality.
Methods: A single-center, 10-year
retrospective review of all patients
diagnosed with heterotaxy syndrome
who underwent cardiovascular surgical repair from January 2008 to
December 2017. Diagnosis of heterotaxy syndrome was based upon evaluation of thoracoabdominal situs by
echocardiography. Patients were classifed as either single ventricle (SV)
or biventricular (BV) according to
their functional anatomy after repair.
Univariate and multivariable Cox
regression analysis and Kaplan-Meier
analysis for survival were performed.
Results: Eighty-two patients with
heterotaxy syndrome met inclusion
criteria. Fifty-five patients (67%)
underwent SV palliation and twentyseven (33%) underwent complete BV

46

0

4

5

15

14

6

4

2
3
Years since First Procedure

Number at risk

sv 55

36

29

Bt-V 27

14

14

I-

20
10

sv

Bi-VI

FIGURE: Overall Survival of Patients with Heterotaxy Sydrome
repair. Patient mortality in the entire
cohort was 34% (28/82) including 36%
(20/55) for SV palliation and 30% (8/27)
for BV repair. Interstage mortality
among SV patients was 29% after
stage 1 (12/46), 17% after stage 2 (7/42),
and 4% after stage 3 (1/23). Among all
heterotaxy patients, independent risk
factors for mortality included pre- or
post-operative ECMO (HR=10.4;
95% CI: 4.3-25.4; P<0.001), TAPVR
(HR=4.3; 95% CI: 1.7-10.8; P=0.002),
and body weight <2500g (HR=2.4; 95%
CI: 1.0-5.4; P=0.041). Among patients
undergoing SV palliation, signifcant
multivariable risk factors for mortality included ECMO (HR=11.0; 95%
CI: 3.6-34.2; P<0.001) and TAPVR
(HR=7.0; 95% CI: 2.3-21.7; P=0.001).
Pulmonary vein stenosis was a signifcant univariate predictor of mortality among all heterotaxy patients
(HR=3.0; 95% CI: 1.4-6.4; P=0.005)
and in the subgroup of SV patients
(HR=4.0; 95% CI: 1.7-9.7; P=0.002).
Overall survival of all heterotaxy
patients was 66% (54/82) at a median
follow-up time of 2.2 years (0.4-4.1)
from the frst operation (Figure).

Conclusions: Despite advancements
in perioperative care and refnement of
cardiovascular operative techniques,
there is still considerable mortality in
children with heterotaxy syndrome in
the current era. Signifcant risk factors
for mortality in these patients include
body weight <2500g, TAPVR, and
ECMO, which may help to further
inform surgical decision-making.
Surgeons should proceed with caution
in patients with pulmonary vein stenosis, as this is a signifcant predictor
of mortality irrespective of the functional cardiac anatomy after repair.
There was comparable observed survival after the frst procedure, though
objective overall long-term survival
was higher in those who received
complete biventricular repair. Further
understanding of this complex patient
population is needed to overcome poor
prognostic factors and improve overall
long-term survival.
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Proximal femur and pelvic osteotomies are commonly used to correct
spastic hip dislocations in children
with cerebral palsy (CP). Treatment
of postoperative pain, in these often
cognitively impaired children, is challenged by difficulty self-reporting
pain. 1,2,3 While undertreated pain
causes suffering, overtreatment can
precipitate respiratory compromise
in this vulnerable population.1,3,4 In
patients with CP undergoing spine
surgery, epidural analgesia has been
shown to decrease intensive care unit
admissions due to respiratory decompensation.4 Thus many centers are also
using epidural anesthesia for children
undergoing lower extremity surgery.
Epidural analgesia is often continued for 2-3 days, during which time
a Foley catheter is left in place until
the epidural catheter is discontinued.5
Neural-blockade in unilateral surgeries
often delays physical therapy, further
delaying patient discharge. This study
sought to determine if there was a
difference in pain control between
the use of epidural analgesia versus
non-epidural pain control modalities

for patients with neuromuscular conditions undergoing unilateral hip reconstruction. Additionally, we sought to
quantify diferences in length of stay
between the two populations.
Methods: Following approval from
the Institutional Review Board, we
performed a retrospective chart review
of pediatric hip reconstructive procedures in which either epidural or
non-epidural analgesia was administered for postoperative pain relief.
We identifed patients who underwent
unilateral or bilateral proximal femoral
osteotomies, pelvic osteotomies, or
hip open reductions from Jan. 01,
2009 to Dec. 2, 2019, which yielded
227 patients. We excluded patients
who had a revision surgery and those
without neuromuscular conditions.
The fnal cohort consisted of 82 cases
that met all criteria, of which 66
underwent unilateral procedures.
Demographics, laterality of surgery,
postoperative pain control modality,
duration of pain control modality,
and length of stay at hospital were
recorded. Pain scores were recorded
using the FLACC pain scale.
Results: Of the patients undergoing
unilateral procedures, 37 used nonepidural pain-control modalities,
and 29 used epidural analgesia. The
average ages of the epidural group and
non-epidural group were 8.82 years and
10.61 years, respectively. The epidural
group had median, mean, high, and low
pain scores for the length of their stay
of 3.5, 3.45, 5.93, and 1.31, respectively.
The epidural group had a mean length
of stay of 6.34 days. The non-epidural
group had median, mean, high, and low
pain scores for the length of their stay
of 3.43, 3.62, 6.27, and 1.77, respectively.
The non-epidural group had a mean
length of stay of 4.41 days. An unpaired
t-test was used to analyze the data, and
there were no signifcant diferences in
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median (p=0.84), mean (p=0.52), high
(p=0.54), and low (p=0.09) pain scores
between the epidural and non-epidural
groups. There was also no signifcant
diference (p=0.09) in the length of stay
between the groups.
Conclusion: There were no signifcant diferences in pain scores or
length of stay between the epidural
and non-epidural groups.
Signifcance: These results suggest
that patients undergoing unilateral
hip reconstruction do not beneft from
epidural analgesia when compared to
non-epidural pain control modalities.
We are hopeful that this will allow
practitioners to standardize postoperative pain control in this patient
population.
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Mandibular distraction osteogenesis (MDO) is a staged intervention
frequently used to address airway
obstruction in infants with Robin
Sequence (RS). Facial nerve dysfunction (FND) is a well-known but poorly
documented complication that may
occur during device placement/osteotomies, active distraction/lengthening,
consolidation, and/or device removal.
The aim of our study was to precisely
and fully document this adverse event
in our recent experience to identify
possible risk factors that may be associated with this increasingly popular
surgical airway procedure.
Methods: A retrospective review
of a prospectively gathered database
was performed to identify patients
with RS that underwent MDO at
our institution from March 2013 to
June 2020. We included all infants
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who did not exhibit FND, had early
following distractor placement/
resolution of FND, or had FND with
osteotomies or device removal.
at least three months follow-up after
Conclusions: FND associated with
device removal. Basic demographic
MDO for infants with RS is not
data and factors potentially related
uncommon. Our study demonstrated
to FND were documented, including
that most cases of FND occurred
onset, laterality, time to resolution,
during the active distraction phase,
and incidence of long-term palsy.
likely due to a stretch injur y of
Result s: 23 patients w ith R S
the marginal mandibular branch.
were included in the analysis. 56.5%
While the majority of FND cases
of patients were female and the
are transient, a small proportion
majority of patients had an associated
may persist. Future studies must
syndromic diagnosis
(65.21%, n=15). Average
age at the time of
Our study demonstrated that most cases of
d e v ice pl a cement
was 2.4 months. Mean
FND occurred during the active distraction
latency, distraction
a nd consol idation
phase, likely due to a stretch injury of the
phase were 1.9 days,
19.1 days, and 82.1
marginal mandibular branch.
days, respectively.
Mean distraction rate
was 1.2 mm/day. FND
aim to characterize risk factors for
was documented in 39.1% (n=9) of
FND, as well as identify strategies
patients, six of which were temporary.
for mitigating the risk of this adverse
The majority of FND cases occurred
event.
during the distraction phase and
Objective: This study is the first
one FND during the consolidation
to characterize the prevalence of
period. FND persisted in 3 patients
permanent and transient facial nerve
for a mean of 25 months after device
dysfunction experienced by a cohort
removal. All FND cases involved the
of RS patients following MDO at a
marginal mandibular branch, with
single institution in recent years.
one patient presenting with additional
involvement of zygomatic branch.
FND was not detected immediately
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Radiosurgery for Brain Metastases From Ovarian Cancer:
An Analysis of 25 Years’ Experience with Gamma Knife Treatment
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Cerebral metastases from gynecological tumors are rare and usually develop
late in the course of the disease. The
incidence of brain metastases in
ovarian cancer is between 1% and 3%
with a recent increase likely related to
earlier diagnosis with modern imaging
techniques (CT, MRI, PET) and more
efective systemic therapies allowing
prolongation of the patient’s life.1,2
Life expectancy in these patients is
poor. Typically, the treatment of brain
metastasis in patients with ovarian
cancer has consisted of a multimodal
approach including surgery, radiation, and chemotherapy. Whole brain
radiation therapy (WBRT) for brain
metastases has not changed its poor
prognosis and very short survival.
Stereotactic radiosurgery (SRS) is
becoming a new paradigm in the management of these patients, in which
high doses of collimated radiation are
delivered by a linear accelerator or by
a Gamma Knife.
A retrospective analysis of all
patients with ovarian cancer treated
with Gamma Knife SRS (GKRS)
at outpatient centers from October
1993 to January 2019 was performed.

Characteristics

Median (range) Mean (range)

Total Number

Percentage

Age (years)

60 (39–79)
90

7

78%

80

2

22%

KPS %

60 (39–79)

90

No of brain
metastases

88

2 (1–11)

3 (1–11)

1 -

-

4

44%

-

-

5

56%

>2
Location of brain
metastases

45

Supratentorial

-

-

29

64%

Infratentorial

-

-

16

36%

Tumor volume at
GKRS (cm³)

1 9 (0 4–30 3)

Prescribed dose (Gy)
Previous treatment

39

17

15 8

-

-

9

100%

Chemotherapy

-

-

9

100%

Resection of primary

-

-

9

100%

Surgery of metastatic
disease

-

-

2

22%

WBRT

-

-

1

12%

50

54

Radiotherapy

Follow-up time
(months)

Inclusion criteria included tissueconfirmed diagnosis of epithelial
ovarian cancer with evidence of brain
metastases as diagnosed by computed
tomography (CT ) and magnetic
resonance imaging (MRI). Karnofsky
score (KPS), age at diagnosis, radiosurgery dose, and survival time were
analyzed. Of 872 women diagnosed
and treated for brain metastases in
the center, nine had primary ovarian
cancer (1.03%). At presentation six of
the nine patients had a KPS of 90%,
one with 80% and two patients had no
documented score. The median age at
f rst treatment was 57 years old.
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Radiosurgery in these patients
was done by GKRS that delivers
a high-dose fraction radiation to
the target using Cobalt-60 as the
radioactive source. A stereotactic
frame fixed to the patient’s head
resulted in unsurpassed accuracy and
precision. A brain MRI with contrast
was obtained immediately prior to
the treatment. The following organs
at risk were contoured: brainstem,
optic chiasm, optic nerves, lens and
any other of pertinent structure.
Forty-two metastases were treated
Continued on p. 50
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Continued fom p. 49
w ith 16 procedures in the nine
patients.
In this group of patients, the
interval between diagnosis of ovarian
carcinoma and development of brain
metastases ranged from -1.0 to 125.5
months with a median of 31.5 months.
The -1.0 stands for one patient whose
brain metastasis was found prior
to the primary tumor. The median
overall survival time estimate from
original diagnosis of ovarian cancer
(OS2) was 48 months, ranging from
10.6 to 148.4 months. The median
overall survival after GKRS (OS1)
was 10.6 months ranging from 2.5 to
81.1 months.
Although this study should be
interpreted with caution because of
the limited number of patients, our
results are in accordance with the current published literature. In general,
the median survival after diagnosis of
brain metastases is usually six months;
nevertheless, better survival can be
achieved when multimodality therapy
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FIGURE:
is used. GKRS is a valuable modality
for management of brain metastases
that is minimally invasive and well
tolerated.
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A Retrospective Analysis of Trigger Point Injections in
the Management of Post-surgical Pain in Patients
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TABLE: Primary outcomes of anterior cervical surgery patients receiving postoperative
standard pain control versus trigger point injection at multiple time points
Standard Care (n=47)

Trigger Point
Injection (n=28)

(mg)

(mg)

6 hours

32±2 8 (n=47)

22±3 0 (n=28)

0.025*

12 hours

54±5 1 (n=29)

37±10 5 (n=9)

0 18

24 hours

78±7 1 (n=27)

58±18 9 (n=6)

0 35

6 hours

3 4±0 4 (n=47)

3 3±0 4 (n=28)

0 78

12 hours

5 3±0 6 (n=29)

4 2±1 3 (n=9)

0 45

24 hours

5 4±0 6 (n=27)

3 2±1 5 (n=6)

0 21

Outcome
OME
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p-value
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The opioid epidemic has launched
the United States into a public health
crisis, resulting in a greater emphasis
on non-opioid multimodal pain control methods. At our institution, postoperative posterior neck stifness and
myofascial pain is a common concern
after anterior cervical surgery (ACS),
likely due to prolonged intraoperative
positioning in neck extension. Studies
have shown successful analgesic
outcomes of trigger point injections
with local anesthetic for generalized
myofascial pain.1,2 This retrospective
pilot study aimed to evaluate whether
trigger point injections with bupivacaine decrease postsurgical pain
compared with traditional therapies
in patients undergoing ACS and
thereby decrease the amount of opioid
medication used.
Methods: We retrospectively
reviewed all ACS cases from January
2019 to Ma rch 2020 at a single
university hospital. We identified
patients who received trigger point
injections with 0.25% bupivacaine
(TP) versus standard care (SC). In the
TP group, only one TP was performed
and administered in multiple locations
along the bilateral trapezii and rhombi

Data presented as Mean±Standard Deviation, OME: Oral Morphine Equivalent, VAS:
Visual Analog Scale, * p-value was <0 05
by an anesthesiologist. Patients were
excluded if TP was performed >3
hours from surgery, if patient was
in recovery for opioid use disorder,
under went a posterior approach,
staged surgery, or sustained cervical
trauma. The primary outcomes were
pain control through the Visual
Analog Scale (VAS) and calculated
oral morphine equivalents (OME)
taken at 6, 12, and 24 hours postoperatively. Secondar y outcomes
included length of stay. Statistical
analysis was performed, and p-values
were based on Welch’s t-test.
Results: There were 137 patients
who received anterior cervical surgery
(100 SC, 37 TP), and 62 were excluded.
A total of 75 (47 SC, 28 TP) patients
were included in this study. The
average age of patients was 56 years
old. The average OME at 6 hours was
signifcantly lower when comparing
SC vs TP (32 vs 22, p=0.025). There was
no signifcant diference in average
VAS at all time points and average
OME at 12 and 24 hours (Table).
50% of patients were discharged by
18 hours.

CLINICAL RESEARCH | SURGERY AND ANESTHESIA

Discussion: Within six hours of
the postoperative period, TP led to
signifcantly lower opioid consumption,
without afecting overall pain level.
Therefore, in this retrospective study,
TP is an efective alternative opioidsparing method of pain control for
myofascial neck pain in the immediate
postoperative period after ACS. This
is an important consideration for pain
control management during the opioid
epidemic.
Limitations of this retrospective
study were the small number of study
participants, that many patients were
discharged before 18 hours, and that
some may have been on chronic pain
therapy. Using the lessons learned
here, a prospective double-blinded
randomized controlled study will be
designed and conducted to compare
with the results of this retrospective
study. Additionally, future studies can
continue to ascertain effectiveness
while also assessing for safety and
generalizability across other types of
surgeries.
Continued on p. 52
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Many male patients have desired elimination of their feminine-appearing
breast, termed gynecomastia. These
patients have desired maximal fattening of their chest. We present a
new set of patients who instead desire
a more muscular-appearing chest
than a gynecomastia repair that is
interposed on a chiseled abdominal
contour. In contrast to the former
set of patients, these patients desire
bulking of their breasts with a bolderappearing armor plate look. We
present an alternative to traditional
gynecomastia repair which involves
a novel approach to chest contouring
creating a fat, yet bold, pentagonalshaped breast with linear borders
utilizing both fat and gland removal
as well as strategic fat grafting back
into the chest to create an armor plate
appearance.
Methods: This study reviews the
technique of chest optimization on a
cohort of 38 males with ages ranging
from 21 to 62 years old (average, 37.5
years old). Patients are treated with
a combination of intra-muscular and
subcutaneous fat grafting strategically to create a pentagonal-shaped
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FIGURE 1: Preoperative markings of chest masculinization protocol Plus signs
indicate regions where fat is added, whereas minus signs indicate regions fat will be
subtracted This strategic placement of fat helps us to create a pentagonal-shaped chest
with bold and linear borders
chest with bold and linear borders
(Figure 1). Intramuscular fat injection
is performed along the vertical medial
line. This injection of fat into the
pectoralis muscle performed simultaneously with gynecomastia repair
allows for masculine appearance of
the chest. Fat graft amount ranges
between 60 and 350 cc injected to each
chest side (average, 150 cc). Tumescent
solution is used to infltrate and aspirate (roughly 2–4 mL of solution for
each milliliter of aspirated volume).
Average infltration varies between
100– 300 (right) and 100–280 (left)
with an average of 150 (both right
and left. Fat graft is grafted into the
pectorals (10 cc injected into single

prominent inscription). Photographs
are taken at the 3- to 4-month mark
for each patient. No complications
were found in all cases.
Results: Below, we have demonstrated three cases of an armor male
chest contour interposed on a harmonious masculinized abdominal
contour. All patients, 6-month postsurgery, demonstrate a pentagonal
shaped chest with bold and linear
borders (Figures 2). Patients were
monitored, and no complications were
experienced.
Conclusion: The armor plate chest
appearance provides a more masculine male chest appearance. We
represent this alternative approach
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to traditional gynecomastia repair
technique since it achieves a more
muscular-appearing chest contour
that is more harmonious on a male
patient u ndergoi n g abdom i n a l
etching. Further monitoring and
precise evaluation of patients will
expand on the evaluation of fat-cell
survival and needed to determine the
efcaciousness of this technique.
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FIGURE 2: Male chest contouring to create a masculinized armor plate appearance
A 34-year-old male three months following ultrasound-assisted liposuction of the
abdomen, lateral chest, pubic region, and fat grafting to the chest Patient demonstrates
linear chest borders post-operation creating a more masculinized appearance
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Same-day discharge pathways may
increase patient satisfaction and
reduce overall costs in total knee
arthroplasty (TKA).1,2 These pathways ofer potential advantages but
have not been thoroughly evaluated
in potentially at-risk populations,
such as in patients ≥80 years old.3 The
purpose of this study was to compare
90-day complications and mortality
following same-day discharge after
primary TKA in patients ≥80 years
old and those <80 years old.
Methods: Patients who underwent
unilateral TKA, were discharged
on postoperative day 0, and had a
minimum 90-day follow-up were identifed in a national insurance claims
database (PearlDiver Technologies)
using CPT code 27447. These patients
were stratifed into two cohorts based
upon age: 1) non-octogenarians (<80
years old) and 2) octogenarians (≥80
years old). These cohorts were propensity matched based upon sex,
Charlson Comorbidity Index, and
obesity status. Univariate analysis was
performed to determine diferences in
90-day complications and mortality
between the two cohorts.
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TABLE: Univariate analysis of 90-day complications following same-day discharge
after total knee arthroplasty
Total
(n = 2222)

Octogenarians
(n = 1111)

%

Nonoctogenarians
(n = 1111)

%

p-value

Anemia

429

227

20.43%

202

18.18%

0.179

Arrhythmia w/

347

231

20.79%

116

10.44%

<0.001

155

93

8.37%

62

5.58%

0.009

llfih.
Arrhythmia w/o

8All.
Bleeding
complication
Blood
Transfusion
Cellulitis

20

12

1.08%

8

0.72%

0.368

108

59

5.31%

49

4.41%

0.324

69

41

3.69%

28

2.52%

0.111

MI

135

65

5.85%

70

6.30%

0.657

50

4.50%

24

2.16%

0.002

Pneumonia

Stroke
Death
DVT

1

74
53

34

3.06%

19

1.71%

0.037

61

30

2.70%

31

2.79%

0.896

77

39

3.51%

38

3.42%

0.907

Heart Failure

200

117

10.53%

83

7.47%

0.012

Pulmonary
Embolism
Respiratory
Complication
UTI

49

26

2.34%

23

2.07%

0.665

32

17

1.53%

15

1.35%

0.722

263

159

14.31%

104

9.36%

<0.001

41

23

2.07%

18

1.62%

0.431

Sepsis

l

*Bold values indicate statistical signifcance Afb: atrial fbrillation; MI: myocardial
infarction; DVT: deep vein thrombosis; UTI: urinary tract infection
Results: In total, 1,111 patients were
included in each cohort. Both cohorts
were successfully matched, with no
obser ved differences in matched
parameters for demographics or
comorbidities. There was no signifcant diference in 90-day mortality
between the two cohorts (p=0.896).
However, octogenarians were at signifcantly increased risk of postoperative atrial fbrillation (20.8% vs. 10.4%;
p<0.001), pneumonia (4.5% vs. 2.2%;
p=0.002), and urinary tract infection
(14.3% vs 9.4%; p<0.001) compared to
the non-octogenarian cohort.
Conclusion: Relative to matched
controls, octogenarians are at significantly increased risk of medical
complications within 90 days following same-day primar y TK A,
including cardiac arrhythmias, pneumonia, and urinary tract infection.
Clinicians should place emphasis on

the increased risk of these complications when counseling patients and
should practice careful patient selection when performing same-day TKA
in the octogenarian population.
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Hip disorders, such as hip subluxation, dislocation, and developmental
dysplasia of the hip, afect approximately one-third of children with
cerebral palsy (CP).1 These disorders
result from a combination of spastic
muscles placing abnormal forces on
the hip joint, resulting in subluxation
and bony deformities.2 Treatments
include non-operative (physica l
therapy, orthotics, medications) and
operative management.3 Femoral and
acetabular reconstructive surgeries
are the primary surgical interventions
for hip disorders in CP patients, but
there is no consensus on postoperative
immobilization method.4
Postoperative protocols following
hip reconstruction in children with
CP include physical therapy, cast
immobilization (hip spica, petrie
cast), abduction pillows, and pain
management. Cast immobilization is
used to achieve stability and prevent
early dislocation but poses risk of
serious orthopaedic complications.5
Currently, postoperative immobilization method is determined

by surgeon preference. This study
abduction pillow. Within the spica
sought to inform postoperative progroup, 23% underwent hip procetocol by evaluating the effects of
dures, 10% underwent femur proceseveral methods of postoperative
dures, and 67% underwent combined
immobilization in patients with
hip and femur procedures. Of these
neuromuscular conditions following
procedures, 53% included an open
hip reconstruction and determining
reduction. Within the Petrie group,
which postoperative immobilization
6% underwent hip procedures, 17%
technique leads to the fewest number
underwent femur procedures, and
of complications.
77% underwent combined hip and
Methods: Following approval from
femur procedures. Of these procethe Institutional Review Board, we
dures, 60% included an open reducperformed a retrospective chart
tion. Within the abduction pillow
review of pediatric hip
reconstructive proceThese results suggest that patients with
dures in which either a
spica cast, Petrie cast,
neuromuscular conditions undergoing hip
or abduction pillow was
placed for postoperative
reconstruction do not additionally beneft
hip immobilization. We
identifed patients who
from spica or Petrie casting in the setting
under went unilateral
or bilateral proximal
femoral osteotomies,
where an open reduction is not performed.
pelvic osteotomies, or
h ip open reductions
from 01/01/2009 - 12/02/2019, which
group, 13% underwent hip procedures,
yielded 227 patients. We excluded
47% underwent femur procedures,
patients who had a revision surgery
and 40% underwent combined hip
and those without neuromuscular
and femur procedures. Of these
conditions. The final cohort conprocedures, 7% included an open
sisted of 82 cases that met all criteria.
reduction. The complication rates,
Demographics, laterality of surgery,
as defined in the methods section,
type of procedure, postoperative
were 21.9% for the spica cast group,
hip immobilization technique, and
17.1% for Petrie cast, and 13.3% for
30-day postoperative complications
abduction pillow. A chi-squared test
were recorded. Complications were
was used to analyze the data, and
defined as readmission to hospital
there was no significant difference
for a respiratory or orthopedic issue,
in complication rates among spica
including but not limited to re-discast, Petrie cast, or abduction pillow
location or loss of surgical fxation.
groups (p=0.76).
Additionally, we included soft-tissue
Conclusion: There was no sigcomplications, such as pressure ulcers
nificant difference in complication
or any superficial or deep wound
rates among the three methods of
infection.
immobilization.
Results: Of the 82 patients, 32
received spica casting, 35 received
Petrie casting, and 15 received an
Continued on p. 56
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postoperative hip immobilization in
this patient population.
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Transfusion-associated hyperkalemic cardiac arrest (TAHCA) is an
adverse outcome associated with red
blood cell (RBC) transfusion. During
refrigerated storage, RBCs undergo a
series of morphological, functional,
and metabolic changes that are collectively termed ‘the red blood cell
storage lesion.’ The RBC storage
lesion occurs in part to a progressive
increase in extracellular potassium as
cation transporters, including Na+/
K+ ATPase, are impaired during

hypothermic storage. Blood product
be mitigated by using fresh blood
irradiation further increases extraproducts, reducing storage time
cellular [K+], as it increases the perafter blood product irradiation, and
meability of the RBC membrane.
implementing of post-transfusion
Consequently, rapid or large volume
manipulations that wash or remove
transfusions can predispose patients
excess extracellular potassium.
to hyperkalemia and electrical instaConclusion: Advances in transfubilities, including cardiac arrest.
sion medicine have improved the
Objective: We aimed to review the
quality of RBCs during storage;
literature on the incidence of transfudespite these advances, vulnerable
sion-associated hyperkalemia, highpatient populations experience translight the association
with cardiac electrical
Advances in transfusion medicine have
instabilities, and identify potential mitigation
improved the quality of RBCs during
strategies to reduce the
risk of hyperkalemia
storage; despite these advances, vulnerable
in transfused pediatric
patient populations.
patient populations experience transfusionResults: We identified 21 case reports of
associated hyperkalemia.
TAHCA in pediatric
patients. Hyperkalemia
and cardiac electrical
instabilities were more commonly
fusion-associated hy perkalemia.
reported in pediatric patients if blood
Mitigation strategies may help to
products were transfused quickly,
reduce the risk of TAHCA, which
were delivered directly to the heart
is associated with poor short-term
without adequate time for electrolyte
survival rate following rapid blood
equilibration, or when blood products
administration.2
had accumulated extracellular potasREFERENCE:
sium due to prolonged storage or
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following irradiation. We note that
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hyperkalemia and/or TACHCA may
Published online 2011:2.
be underreported due to incomplete
2. Demaret P, Tucci M, Ducruet T, Trottier
hemovigilance reporting systems.1
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Collectively, the 21 reports suggest
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that the risk of hyperkalemia may
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Autonomic Tone in Preterm Infants Correlates with
Morbidity of Prematurity
seem to infuence ANS development
to term in a preterm population with
a relatively low level of prematurityrelated complications.1 GA at birth
ADVISORS: Sarah
may therefore have less impact on
D Schlatterer, MD,
ANS development than previously
PhD,1,2 and Sarah
thought. Prior studies investigating
B Mulkey, MD,
1,2
ANS maturation in preterm infants
PhD
have predominantly involved infants
1 Children’s National Hospital
with higher levels of prematurity2 Department of Neurology and Department
related complications,1,2 so it may be
of Pediatrics, George Washington University
that ANS development in the preterm
School of Medicine and Health Sciences
infant is more related to medical
comorbidities than birth GA. Given
recent evidence that GA at birth may
have less impact on ANS maturation
An appropriately mature autonomic
than previously thought, we hypothner vous system (ANS) is key for
esized that the medical complexity
transition from the intrauterine to
of preterm infants
correlates with ANS
maturation. For the
Understanding how medical complexity
p u r p o s e s of t h i s
study, we considered
impacts ANS development in preterm infants
medical complexity
to i nclude a ny of
may lead to future advances in NICU care.
the following at any
time during admission: culture positive
1
infection, necrotizing enterocolitis
extrauterine environment at birth,
(NEC) diagnosis, presence of a patent
and abnormal ANS development has
ductus arteriosus requiring medical
been linked to neurodevelopmental,
or surgical intervention or hemodyneuropsychiatric, and cardiovascular
namic instability requiring pressors,
outcomes later in life. The ANS
brain injur y on head ultrasound
undergoes a critical period of maturaincluding periventricular leukomation during the latter half of gestation
lacia and intraventricular hemorrhage
and during the early neonatal period.
grade 3 or 4, and need for mechanical
Previous studies have found that preventilation/intubation.
term birth and subsequent maturaIn this study, we set out to detertion in the extrauterine environment
1,2
mine the degree to which comcan impact A NS development.
plications of prematurity impact
However, it is likely that multiple
ANS development by comparing
factors impact ANS development in
114 preterm infants (birth GA ≤33
the extrauterine environment beyond
weeks) divided into two groups with
gestational age (GA) at birth. Our
differing levels of complications of
group recently showed that duration
prematurity. Group 1 included infants
of extrauterine development did not

Sneha Iyer,
MSIII
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without signifcant complications of
prematurity, while group 2 included
infants with medical or surgical complications of prematurity. Weekly
electrocardiogram (ECG) data was
assessed from admission to neonatal
intensive care units (NICU ) discharge. ANS tone was determined by
heart rate variability (HRV) analysis
in time and frequency domains.
Normalized low frequency, alpha 1,
and root mean square 1 characterized
sympathetic tone, while normalized
high frequency characterized parasympathetic tone. Median regression
with a group by time interaction term
was used to model ANS maturation
across days of life and evaluate any differences in maturation rates between
groups.
Overall, we found that cohorts of
preterm infants with difering levels
of medical complexity show diferences in their ANS development,
specifcally for time-domain metrics
of HRV. The results indicated that
medical comorbidities, and, perhaps,
the negative experiences associated
with illness, do impact the trajectory of ANS development in preterm
infants. Understanding how medical
complexity impacts ANS development in preterm infants may lead to
future advances in NICU care.
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A 52-year-old male with a past medical
history signifcant for hypertrophic
ca rd iomyopathy ( HC M ), atr ia l
f ibr i l lation, hy per tension, a nd
hy perlipidemia presented to a n
outside hospital for pre-syncopal
episodes. Prior to presentation, he was
experiencing persistent, symptomatic
palpitations with heart rates in the
110s, and his verapamil dose was
increased from 120mg to 240mg
daily. In addition, the patient was
also being managed with metoprolol
tartrate 100mg BID, amiodarone,
and rivaroxaban. The patient arrived
at the hospital with shortness of
breath, cyanosis, hypotension, and
bradycardia. He endorsed alcohol
use the day before with burning
abdominal pain and weakness at
that time. He was subsequently
int ubated, paced, a nd required
pressor support with norepinephrine
and epinephrine. His verapamil
was also held at this time. His labs
are listed in the table below. Given
his worsening liver function tests,
and a Model for End-Stage Liver
Disease (MELD) Score of 39, he was
transferred to a transplant center
for evaluation for liver transplant.
Liver biopsy was consistent with
hypoxic injury. Extensive workup
for other etiologies of liver failure,
including viral hepatitis panel, and
autoimmune hepatitis panel were
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FIGURE: Mechanism of action of DHP (A) and non-DHP (B) calcium channel blockers
(Wecker, 2019, pp 325-329)
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a ll negative. The patient’s liver
function continued to improve over
the course of his hospitalization
without need for transplant, but
renal function did not recover, and
he was transferred to our facility for
hemodialysis initiation. He continued
to remain in atrial fbrillation over
the course of the hospitalization with
heart rate sustained in 140s bpm.
His metoprolol tartrate dose was
increased to 125mg BID for better
rate control. His hospital course was
otherwise complicated by Klebsiella
venti lator-acqu i red pneu mon ia
( VAP) and post-traumatic stress
disorder (PTSD) from the protracted
hospital course.
Discussion: Verapamil is a calcium
channel blocker commonly used
to treat hypertension and provide
rate control for atrial fibrillation/
f lutter. It has a strong affinity for
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both myocardial and vascular smooth
muscle, allowing it to exert its efects
not only on the musculature of the
heart but also on arterioles throughout
the body. The therapeutic mechanism
is primarily vasodilation, along with
suppressing cardiac contractility,
sinoatrial node automaticity, and
atrioventricular node conduction.1
While this potent vasodilation
is efective in treating patients with
hypertension, it also poses a signifcant
risk profle when taken at doses over
the therapeutic range, most notably
causing bradycardia, hypotension,
cond uc t ion d i st u r ba nce s , a nd
escape rhythms. When progressive,
hypotension and bradycardia can
eventually lead to cardiogenic shock.1
Combination therapy is
ver y commonly used to manage
Continued on p. 60
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Continued fom p. 59
va r ious med ica l cond itions;
however, polypharmacy inherently
increases the risk of adverse events.
Ca rd iogen ic shock has been
reported as a rare complication
associated with the use of verapamil
a nd b et a - blo c ker s . Ver a pa m i l
produces a state of myoca rd ia l
depression, which is usually not
problematic due to a compensatory
sympathetic ref lex. 2 However, the
co-administration of beta-blockers
blunts this compensatory mechanism,
potentiating myocardial depression,
thus posing an increased risk for
cardiogenic shock.3
The aforementioned principles
out l i ne t he r i s k s p os e d w hen
taking doses over the threshold for
therapeutic treatment. 4 The case
presented here remains unique as
the dosage for both the metoprolol
a nd verapa m i l were w ith in the
therapeutic range. Therefore, while
rare, it is important to up-titrate
these medications with caution and
consider the risk for cardiogenic
shock with potential for end-organ
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TABLE: Laboratory Results
BUN

71

PT

57 2

Cr

72

INR

6 42

BUN/Cr

9

PTT

42 9

Tbili

16

Troponin I

0 047

AST

13,112

Lactic Acid

82

ALT

9,553

LDH

47,222

Adenovirus

-

VZV

+

Anti-HAV

-

+

Coxsackie A

-

EBV

Anti-HBV

-

Coxsackie B

-

Quant Gold

-

Anti-HCV

-

Babesiosis

-

HSV IgM

-

Anti-HDV

-

ANA

-

HSV PCR

-

Anti-HEV

-

damage even when delivered within
the therapeutic window.
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Objective: To measure the association
of race, ethnicity, comorbidities, and
insurance status with need for hospitalization of symptomatic Emergency
Department ( ED) patients with
Severe Acute Respiratory Syndrome
C or on a v i r u s 2 ( S A R S - C oV- 2)
infection.
Methods: This study is a retrospective case-series of symptomatic
patients presenting to a single ED with
laboratory-confrmed SARS-CoV-2
infection from March 7 to Aug. 9,
2020. We collected patient-level
information regarding demographics,
public insurance status (Medicare or
Medicaid), comorbidities, level of care
and mortality using a structured chart
review. We compared demographics

and comorbidities of patients who
were (1) able to convalesce at home,
(2) required admission to general
hospital ward, (3) required admission
to intensive care unit (ICU), or (4)
died within 30 days of the index visit.
Multivariable and univariable logistic
regression analyses were performed
to report adjusted odds ratios (aOR)
and the associated 95% confidence
inter vals (95% CI) with hospital
admission versus ED discharge home
and need for intensive care unit (ICU)
admission versus general hospital ward
admission.
Results: In total, 993 patients who
presented to the ED with symptoms
were included in the analysis with
370 (37.3%) patients requiring hospital admission and 70 (7.1%) patients
requiring ICU care. Patients requiring
admission were more likely to be Black
or African American, to be Hispanic
or Latinx, or to have public insurance (either Medicaid or Medicare.)
In multivariable logistic regression
analysis comparing which patients
required hospital admission, Black
race (aOR 1.4, 95% CI 0.7-2.8) and
Hispanic ethnicity (aOR 1.1, 95% CI
0.5-2.0) were associated less with need
for admission than public insurance
(Medicaid: aOR 3.4, 95% CI 2.2-5.4;
Medicare: aOR 2.6, 95% CI 1.2-5.3;
Medicaid and Medicare: aOR 3.6
95% CI 2.1-6.2) and the presence of
hypertension (aOR 1.8, 95% CI 1.22.7), diabetes (aOR 1.6, 95% CI 1.1-2.5),
obesity (aOR 1.7, 95% CI 1.1-2.5), heart
failure (aOR 3.9, 95% CI 1.4-11.2), and
hyperlipidemia (aOR 1.8, 95% CI 1.22.9) were identified as independent
predictors of hospital admission.
When comparing those who needed
ICU admission versus general hospital
ward admission, Medicaid (aOR 2.2,
95% CI 1.0-5.1) and Medicare (aOR 2.0
95% CI 0.7-5.8) were associated with
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ICU admission but Black patients
were less likely (aOR 0.6 95% CI
0.1 - 2.4) and Hispanic patients were
weakly (aOR 1.05 05% CI 0.54 - 2.02)
associated with ICU admission.
Conclusion: Comorbidities and
public insurance are predictors of
more severe illness for patients with
SARS-CoV-2. This study suggests
that the disparities in severity seen
in coronavirus (COVID-19) among
Black and Hispanic patients may be
attributable, in part, to low socioeconomic status and chronic health
conditions.
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Quinolones are antibiotics used
for a wide array of infections. 1,2
Nevertheless, their side efects have
resulted in changes in quinolone
administration by providers.3 In this
study, the trend of quinolone utilization over the years in the emergency
department (ED) was analyzed.
A review of the National Hospital
Ambulatory Medical Care Survey
(NHAMCS) database was performed.
Using drug codes provided by the
Centers for Disease Control and
Prevention (CDC), all patients 18
years and older who were administered or prescribed quinolones were
identified between 2005 and 2015.
Bivariate and multivariate statistical
analyses were used to analyze the
demographics, payment source, and
hospital disposition of the study population. Reasons for ED visit and fnal
diagnoses were also examined.
In 2005, quinolone was administered during 2.8 million visits,
accounting for 2.4% of all ED visits.
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From 2005 to 2009, quinolone utilizawas abdominal pain (9.2%-11.7%).
tion experienced an average relative
The most common fnal diagnosis was
increase each year of 4.5%. From 2010urinary tract infection (12.9%-15.5%).
2015, quinolone use had an average
EDs are prescribing less quinorelative decrease each year of 3.2%.
lones for their patients due to their side
In 2015, quinolone was administered
efects and black box warnings, such as
during 2.7 million visits (1.9% of all
altered mental status and aortic rupED visits, P<0.0001).
Quinolone use
EDs are prescribing less quinolones for their
decreased in both
young adults, ages
patients due to their side effects and black
18-44, and middle
adults, ages 45- 64
box warnings, such as altered mental status
(2 0.1% a nd 1.5 %,
P<0.0001), whereas
and aortic ruptures. Future research should
its use increased in
older adults, ages 65+
(1.8%, P<0.0001).
focus on concomitant increase in other drugs
Quinolone utilization
increased for males
to replace quinolones in the ED.
(1.3%, P<0.0001) and
decreased for females
tures. Future research should focus on
(10.8%, P<0.0001), with its use more
concomitant increase in other drugs to
common in females (56.8%-59.9%).
replace quinolones in the ED.
Quinolone use increased in patients
with Medicare and Medicaid (2.7%
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for visit where quinolone was used

Fusion | 2021

Determining Whether an Individual’s Age or Comorbidities is
Superior in Predicting Mortality in COVID-19 Patients
Aarane
Ratnaseelan,
MSIII
ADVISORS:
Ayal Pierce,
MD;1 Jehshua
Karunakaran, MSIII;1
Eric Heinz, MD, PhD;1 David Yamane, MD;1
Ivy Benjenk, PhD;1 and Wayne Woo2
1 The George Washington University School of
Medicine and Health Sciences
2 The George Washington University

To date, the SARS-CoV-2 coronavirus
(COV ID -19) has rapid ly k i l led
over a million people worldwide. 1
Researchers identified elderly age
and various comorbidities as early
risk factors for mortality. Patterns
observed in Wuhan and early cases
in the United States indicate that the
risk of death increases in those over
65 years old, as well as individuals in
any age group with comorbidities,
including diabetes, heart disease,
and clotting disorders.2 In fact, the
study reported that the mortality
rate for COVID-19 patients is 7%
in people with diabetes, 10% in
people with heart disease, and 15% in
people ≥ 80 years old. Additionally,
for those with cancer, hypertension,
or chronic respiratory disease, the
mortality rate rises to 6% from 1%
in the genera l population. 2 Due
to the inf lux of patients requiring
hospitalization and advanced airway
management (e.g., intubation and
mech a n ica l venti l ation), m a ny
hospitals faced supply shortages
early on in the pandemic. In resource
limited settings over whelmed by
a heavy infection burden, such as
various regions of Italy, reports

emerged of rationing ventilators
and even withholding life-saving
interventions from individuals over
a certain age cut-of.3 This begs the
question of whether healthy elderly
individuals have increased mortality
over their younger counterparts
w ith comorbid conditions. The
Charlson Comorbidity Index (CCI)
is a popular risk adjustment tool for
10-year survival in patients. However,
applying the CCI to COVID-19
patients has not yet been probed.
The objective of this study was to
determine whether age or the CCI
is superior in predicting mortality in
COVID-19 patients.
Methods: Between March and
July 2020, a prospective registr y
containing all COVID-19 admissions
to the George Washington University
Hospital was created. A receiver
operator characteristic (ROC) curve
was created for both age and CCI as
a predictor of mortality. Data was
then divided into age brackets with a
breakdown of CCI quartiles for each
bracket.
Results: In total, 369 patients
were studied. Mean age was 61.5
years and CCI was 3.91. The ROC
curve for CCI yielded an Area under
the Curve (AOC) of 0.6476 (0.57–
0.72), while that for age yielded an
AOC of 0.6737 (0.60–0.75). ROC
contrast estimation of these two
predictors did not indicate that
one was significantly better than
the other. When age groups were
analyzed by CCI, there were certain
healthy older age groups with better
survival than their younger, comorbid
counterparts. For example, ≥ 91-yearolds with a lower quartile CCI (0–5,6)
had a 0–33.3% mortality rate. This is
better than 81–90-year-olds with a
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CCI of 7 (57.1%) or CCI ≥ 9 (75%) and
even mortality rates in 61–70-yearolds with a CCI of 5–6 (53.8%) and
7–10 (50.0%).
Conclusions: Both age and CCI are
significant predictors of mortality
for the population represented in
this registry. Comparing the two
did not show a signifcant mortality
difference. However, our study
suggests that one must reconsider
withholding treatment from the
healthy elderly population, as these
patients may have better survival
t h a n t hei r you n g er, but more
comorbid, counterparts. Data may
be confounded by our institution
admitting transfers from outside
institutions and more elderly patients
being made DNR/DNI or CMO than
younger patients. Further studies are
needed to evaluate these trends and to
possibly look at the entire COVID-19
population in Washington, D.C.,
rather than just those admitted to
the hospital.
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Evaluation of Thromboelastography in
Patients with Gastrointestinal Bleeding
TABLE 1: Blood Product Utilization in TEG and non-TEG patients
TEG

Non-TEG

Mean pRBC - Days 0 and 1**

2 93

5 622

Mean FFP - Days 0 and 1**

0 469

2 49

Mean All Productsa - Days 0 and 1**

3 59

9 09

4

6 42

All Patients

Alex Jett, MSII

Negative Binomial Regression
Mean All Productsa - Days 0 and 1**
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MSII; Bridget
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a pRBC plus cryoprecipitate plus platelets plus fresh frozen plasma (FFP)
** p < 0 01
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Thromboelastography (TEG) is a
low-cost, point-of-care diagnostic
test used to quantitatively assess
platelet function, clot formation,
and fibrinolysis. TEG is increasingly employed to guide transfusion
therapy in trauma and surgical cases
to decrease mortality and blood
product transfusion.1,2 These populations are distinctly diferent from the
medical population, which carries different comorbidities, risk factors and
baseline antiplatelet/anticoagulant
use. The most common subset of medical patients with acute bleeding are
those with gastrointestinal bleeding
(GIB). To our knowledge, the utility
of TEG in patients with GIB is not
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well described to date. We sought to
of a transfusion-dependent anemia
assess whether TEG has a beneft in
or hematological disorder, had a left
patients with clinically significant
ventricular assist device, were in carGIB by examining blood product
diac arrest on admission, or had preutilization.
sumed shock from a non-hemorrhagic
Methods: A retrospective chart
etiology.
review was performed on patients who
Results: TEG patients had signifwere admitted between 01/01/2017
cantly greater numbers of total blood
and 12/30/2019 to our intensive care
products (packed red blood cells
unit with an ICD 10 diagnosis code
(pRBC), cryoprecipitate, platelets,
of “hematemesis”
( K92.0), “melena”
(K92.1), or “gastroinThe use of TEG for patients presenting with GIB
testinal hemorrhage,
unspecific” (K92.2).
resulted in increased pRBC and FFP transfuPatients greater than
18 years of age were
sions without any change in clinical outcomes
included in the study
if they had a clinias compared to the standard of care.
cally signifcant GIB,
defned as receiving
an administration
of a blood transfusion for the GI
and fresh frozen plasma (FFP)) trans3
bleed. After this initial stratificafused than the non-TEG patients
tion, patients were excluded from the
during GIB days 0 and 1 (mean 9.09
study if they were DNR/DNI and/
vs. 3.59, p < 0.01). This diference was
or comfort care status on admission,
primarily driven by differences in
had received a documented blood
pRBC (mean 5.622 vs. 2.93, p < 0.01)
transfusion in the preceding two
and FFP (mean 2.49 vs. 0.469, p <
weeks, presented as a trauma, had
0.01). Cryoprecipitate (mean 0.295
respiratory failure or mechanical venvs. 0.015, p < 0.01) and platelet usage
tilation on admission, had a history
(mean 0.688 vs. 0.18, p < 0.01) in
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TEG patients was also signifcantly
higher than in non-TEG patients
on bleed days 0 and 1. Multivariate
analysis revealed that TEG patients
still received a greater total number
of blood products during GIB days 0
and 1 compared to non-TEG patients
(mean 6.42 [95% CI 4.48-8.36] vs.
4.00 [95% CI 3.19-4.80], p < 0.01) even
when controlled for the following
covariates: vasopressor use, sex, race,
age, total comorbidities, shock index,
hemoglobin on admission, platelet
level, hemorrhage control, alcohol
abuse, cirrhosis, abdominal surgeries,
cerebrovascular disease, and malignancy (Table 1). The clinical outcomes
for patients in the TEG and non-TEG
arms were not signifcantly diferent
for most parameters (Table 2).
Conclusions: The use of TEG for
patients presenting with GIB resulted
in increased pRBC and FFP transfusions without any change in clinical
outcomes as compared to the standard of care. Our fndings underscore
the need for a randomized controlled
trial to further elucidate the role
of TEG in medical patients before
routine adoption of its use in these
patients.

TABLE 2: Patient Clinical Outcomes
Non-TEG (n)

TEG (n)

Total

194

61

ICU length of stay (days)

2 77

3 53

Development of Respiratory Failure n (%)

45 (23 2)

19 (31 1)

Mechanical Ventilation Requirement* n (%)

26 (13 4)

16 (26 2)

AKI n (%)

39 (20 1)

10 (16 4)

Renal Replacement Therapy n (%)

4 (2 10)

1 (1 64)

Home

137 (70 6)

40 (65 6)

Death

16 (8 25)

7 (11 5)

Discharge Destination n (%)

* p < 0 05
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This study aims to characterize the
diseases seen in a multispecialty pediatric dermatology-gynecology vulvar
clinic at Children’s National Hospital
(CNH) in Washington, D.C. Though
dermatologic fndings involving the
vulva may present to a variety of
practices, ranging from pediatric primary care, dermatology, gynecology,
or urology, few training programs
provide significant training on the
interdisciplinary knowledge needed
to accurately diagnose pediatric
vulvar dermatologic diseases. To our
knowledge, very few multispecialty
clinics bring together dermatology
and gynecology, especially in a pediatric setting. Based on experience
in our multidisciplinary pediatric
dermatology-gynecology vulvar clinic,
we aim to highlight the benefts of a
multispecialty clinic and showcase the
conditions diagnosed, managed, and
treated. Additionally, we will explore
relevant epidemiological factors seen
in this patient population.
Methods: We conducted a retrospective review of 180 patient charts
from pediatric patients seen at the
joint dermatology-gynecology clinic at
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CNH, at least once between January
highlights the variety of conditions
2016 and June 2020. Data collected
seen and complexity of care faced in
from the charts included patient
a pediatric dermatology-gynecology
diagnosis, demographics, vulvar sympclinic, with emphasis on the risk
toms, and prior care related to the
for a delay in diagnosis when vulvar
patient’s vulvar symptoms. Data was
symptomatolog y is diagnosed in
entered into a RedCap database and
patients seen outside of a dermatologyanalyzed.
gynecology clinic initially. Enhanced
Results: Among the 180 patients
training at the pediatric primary care
seen (mean age 6.89 ±SD 4.63), the
level is needed to help guide clinicians
three most common conditions seen
in accurately diagnosing pediatric
in the clinic are as follows: pediatric
vulvar complaints.
vulvar lichen sclerosus (PVLS) (69.9%),
Keywords: Pediatric dermatology,
vitiligo (21.69%), and vulvovaginitis
pediatric gynecology, multispecialty
(21.69%). In total, 83 conditions were
clinic, pediatric vulvar lichen scleevaluated in this multispecialty clinic.
rosus, vitiligo, vulvovaginitis, vulvar
care.
Approximately 17.8% of patients with
pediatric lichen sclerosis
and 38.9% of patients with
Our study addresses a gap in published
vitiligo were misdiagnosed at least once. On
information on pediatric vulvar
average, from the time of
symptom onset to a diagsymptoms and patient characteristics in
nosis, those with PVLS
wa ited 1 4 .58 mont h s
a multispecialty dermatology-gynecology
and those with vitiligo
waited 10.29 months until
interdisciplinary clinic.
diagnosis. Of those with
PVLS who frst received
a misdiagnosis, 92.8% of
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pediatric vulvar symptoms and patient
American Academy of Dermatology, 44(5),
803-806.
characteristics in a multispecialty
dermatology-gynecology interdisciplinary clinic. The chart review
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Ocular corticosteroids are ubiquitous medications used to treat
a wide variety of conditions that
were previously vision-threatening,
including uveitis, diabetic macular
edema (DME) and retinal vein occlusion (RVO). Despite the therapeutic
value of these medications, they often
induce the elevation of intraocular
pressure (IOP), leading to progressive ocular nerve damage and, in
some cases, to corticosteroid-induced
glaucoma.
For patients in the general population without glaucoma, an estimated
one-third of the population may
be considered “steroid responders,”
indicating that treatment with a
steroid would lead to an increase in
IOP.1 Of the two primary formulations of ocular steroids, topical and
intravitreal, the latter often results in
clinically signifcant IOP elevation,
threatening vision. Although certain
risk factors have been identifed as
predictors for corticosteroid response,
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the variability of outcomes among
were generated for 20 patients using
individual patients continues to
R open-source software. Baseline
render the decision to initiate intravitIOP was not a statistically signifcant
real corticosteroid treatment difcult.
predictor of IOP elevation after treatOne method for assessing an indiment. Regressing average IOP for
vidual’s potential risk of developing a
the four weeks following intravitreal
steroid response following intravitreal
injection compared with the average
injection may be the evaluation of that
IOP for the 3-week intervals following
patient’s IOP following the administopical corticosteroid administration
tration of a topical corticosteroid. Of
yielded an estimated slope of 0.72 with
the topical corticosteroids available on
95%CI of (0.46, 0.99) and R2 =0.57.
the market, Durezol
(difuprednate) is one
of the most potent,
For patients in the general population
contributing to its
utility as an adequate
without glaucoma, an estimated one-third
challenger to elicit
s te r o id r e s p o n s e .
of the population may be considered “steroid
Thus, we hy pothesized that we could
responders,” indicating that treatment with a
identify intravitreal
steroid responders as
steroid would lead to an increase in IOP.1
individuals who experienced elevated IOP
following administraThis study suggests that post-toption of Durezol topical corticosteroid.
ical corticosteroid IOP response is a
A prospective cohort study of
good predictor of the post-intravitreal
29 patients diagnosed with DME or
corticosteroid IOP response, indeRVO over four years (2016-20) was
pendent of baseline IOP, making it a
conducted. IOP was measured at
potentially useful screening process
baseline and at four weekly intervals
for predicting steroid responders.
following topical corticosteroid treatments. After a two-week washout
REFERENCES:
period, intravitreal corticosteroid
1. Feroze KB, Khazaeni L. Steroid Induced
injection was administered, IOP
Glaucoma. [Updated 2020 Jul 21]. In: Statwas then measured at three intervals
Pearls [Internet]. Treasure Island (FL):
post-injection: 2-4; 4-8; 8-12 weeks.
StatPearls Publishing, 2020 Jan. (Accessed
After excluding nine patients with
October 29, 2020 at https://www.ncbi.nlm.
nih.gov/books/NBK430903/)
incomplete steroid courses, linear
models and corresponding plots
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The Role of Regulatory T-Cells in Exercise-Induced
Exacerbation in Chikungunya Arthritis Patients
Methods: On hundred twentyfour Colombian patients with a history of CHIKV infection four years
prior were enrolled (approved by
ADVISORS:
1
The George Washington University
Aileen Chang, MD
Institutional Review Board#121611
and the Clinica de la Costa IRB,
1 Department
Colombia (FWA IORG0008529)).
of Medicine, The
Eleven patients were excluded from
George Washington University
the analysis due lack of serologic confrmation of CHIKV infection (n=9),
Chikungunya virus (CHIKV) is an
lack of blood sample (n=1), or lack of
arbovirus that causes fever, rash,
information on exercise efects (n=1).
myalgia, arthralgia and persistent
One hundred thirteen cases were
arthritis. CHIKV arthritis is symanalyzed. Demographic factors and
metric with relapsing-remitting
measures of arthritis disease severity
symptoms mirroring rheumatoid
are reported. Flow cytometr y of
T-cells was performed on
a BD Celesta fow cytomOur studies are consistent with recent
eter (BD Biosciences, San
Jose, CA) and analyzed in
Treg depleted murine models of arthritis
FlowJo 10 (TreeStar Inc.,
Ashland, OR). We comshowing that voluntary running might
pared outcomes in CHIKV
patients with (n = 38) vs.
play a role in switching off the Tregwithout (n = 75) EIVA using
t-tests to assess means and
the Fisher’s exact test and
mediated resolution of arthritis leading
chi-squared to evaluate cat3
egorical variables (SAS 9.3).
to increased joint infammation.
Results: CHIKV cases
were predom i na ntly
arthritis. In our prior published study
middle-aged Mestizo females with
of a diferent cohort, we found that
at least secondary school education
39% of CHIKV arthritis patients
without history of arthritis prior
reported relapses of CHIKV arthritis
to CHIKV infection. 33.6% of the
1
due to exercise. The underlying
CHIKV cases reported worsening
mechanism of exercise-induced viral
arthritis with exercise. EIVA patients
arthritis (EIVA) relapses is unknown.
reported higher global assessments
The objective of this analysis is to
of arthritis disease ranging from
examine the regulatory T-cell (T-reg)
0-100 (71.2±19.7 vs. 59.9±28.0, p=0.03).
immune response related to CHIKV
Phlebotomy obtained under resting
arthritis fares.
conditions revealed that patients with

Wyn Dobbs,
MSIII
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worsening arthritis from exercise had
lower levels CD4+ T-cells (149,556±
78,196 vs. 186,457±92,167, p= 0.04),
and lower ratios of Tregs/CD4+ T-cells
(1.95±0.73 vs. 2.4±1.29, p = 0.04).
Conclusions: These findings suggest that relative decreases in Treg
populations in patients with CHIKV
arthritis may contribute to arthritis
fares during exercise. Treg cells are
stimulated by exercise in humans and
are suggested to play an acute antiinfammatory role.2 Our studies are
consistent with recent Treg depleted
murine models of arthritis showing
that voluntary running might play a
role in switching of the Treg-mediated
resolution of arthritis leading to
increased joint infammation.3 Studies
of exercise challenge in this population are needed to further defne the
immunologic relationship between
CHIKV arthritis and exercise.
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Chikungunya virus (CHIKV) is a
mosquito-borne virus that causes
persistent arthritis in approximately
one-fourth of patients.1 Preliminary
data suggests that alteration of regulatory T cell function may play a role
in CHIKV arthritis f lares. There
is currently no standard treatment
for this arthritis. The objective of
this analysis is to determine what
treatments are being used currently
by patients and which of those treatments are associated with control
of arthritis symptoms in a Latin
American cohort.
We performed a cross-sectional
analysis of self-reported medication
use and symptom relief among 114
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patients afected by CHIKV infection
cohort of patients with relapsingfrom Atlántico, Colombia for years
remitting chikungunya arthritis
prior. This study was approved by the
in Latin America demonstrates a
ethics committee of the Clinica de
lack of arthritis symptom control in
la Costa (FWA IORG0008529) and
over one third of patients. Over one
The George Washington University
fourth of patients reported using
(#121611).
medicinal plants however little is
All participants in the study were
known about the mechanism of
mestizo in ethnicity. One hundred
action of various local medicinal plant
four of 114 patients (91%) reported
therapies such as including Plantago
years of persistent arthritis attribmajor L. and Terminalia catappa L.
uted to their CHIKV infection from
in the treatment of CHIKV arthritis.
infection 4-5 years prior. Participants
Although both French and Brazilian
reporting persistent arthritis were
guidelines both advise use of methopredominately women with a mean
trexate in the treatment of chronic
age of 48. Of those with
persistent arthritis, 26%
Analysis of the longest follow-up of the
reported using medicinal
plants or alternative medilargest cohort of patients with relapsingcine therapies. However, of
those that reported having
remitting chikungunya arthritis in Latin
their symptoms controlled,
methotrexate and medicinal
America demonstrates a lack of arthritis
plants were the most commonly used therapeutics.
symptom control in over one third of
Only 66% of patients with
arthritis reported that the
therapies they were using
patients.
were able to control their
symptoms. The most commonly used medications
CHIKV arthritis, there is no stanwere paracetamol/acetaminophen
dard evidence-based guidelines for
(94%) and NSAIDS (81%) — and the
the treatment of CHIKV arthritis in
least commonly used was methoColombia and very few patients were
trexate (1%).
using immunomodulating therapy.2
With the results showing a better
control of symptoms in patients
REFERENCES:
taking methotrexate or medicinal
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plans, versus other treatment theraFrequency of Chronic Joint Pain Following
pies, further trials are needed to
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investigate effectiveness of metho& Rheumatolog y. 2018;70(4):578-584.
trexate, medicinal plants and alterdoi:10.1002/art.40384.
native medicine therapies to deter2. Pathak H, Mohan MC, Ravindran V. (2019).
mine pathophysiology and efficacy
Chikungunya arthritis. Clinical medicine
in alphaviral arthritis. Analysis of
(London, England), 19(5), 381–385. https://
doi.org/10.7861/clinmed.2019-0035
the longest follow-up of the largest
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Pregnancy and Child Outcomes Following
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Fetal intracranial hemorrhage (ICH)
is a rare condition, with an estimated
incidence of 0.5-0.9 per 1000 pregnancies, that has potentially severe consequences.¹ Previous studies on fetal
ICH show it has a 40% mortality in
utero or within the frst month of life
and less than 50% of survivors are neurodevelopmentally normal.² Existing
literature defnes fetal ICH and outcome based on prenatal ultrasound,
however fetal MRI is increasingly
used for clinical prenatal diagnosis
and may aid in detection.³ Our objective was to understand pregnancy and
child outcomes following fetal ICH
when diagnosed by fetal MRI.
We performed a retrospective
study of all cases of fetal ICH diagnosed by fetal MRI at Children’s
National Prenatal Pediatrics Institute
from 2012 to 2020. Maternal characteristics, prenatal and postnatal
imaging, ICH type, pregnancy outcome, and infant/child developmental
progress were recorded. Abnormal
postnatal outcomes were categorized
as: mild for hypertonia or physical/
occupational therapy without intellectual disability or language delays;
moderate for intermediate multidomain developmental delays; severe
if non-ambulatory, non-verbal, or
signifcant intellectual disability.
We identifed 57 cases with ICH on
fetal MRI. The mean (SD) maternal
age was 31.1(6.9) years, gestational age
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FIGURE 1: Percentage of specifc pregnancy outcomes compared to ICH type on
fetal MRI

normal in 57%, mildly abnormal in
at fetal evaluation was 28.1(5.3) weeks,
24%, moderately abnormal in 14%,
and birth gestational age was 38.2(1.3)
and severely abnormal in 5%. From
weeks. Pregnancy outcomes consisted
unilateral IVH to parenchymal ICH,
of 75% (n=43) live births, 14% (n=8)
there were 34% more patients with
termination of pregnancy, and 11%
(n=6) intrauterine
demise (IUD). Of
the ICH types, 81%
Fetal MRI description of ICH location may aid
(n=46) were intraventricular hemorin pregnancy outcome prediction and relates
rhage (IVH), 28%
(n=16) were intrapato postnatal neurodevelopmental outcomes.
renchymal and 16%
(n= 9) were both.
Ventriculomegaly
was the most common additional
normal neurodevelopment (Figure
fnding on fetal MRI, seen in 49% of
2). 30% required physical therapy
patients.
and 11% had epilepsy. In fve cases,
From unilateral IVH to both
an etiolog y was identified; 3 had
parenchymal and ventricular ICH,
abnormal placental findings and 2
there were 63% fewer live births
had genetic findings (FNAIT and
a nd 55% more IU D ( Fig u re 1).
COL41A mutation).
86% of live born infants were folOur findings demonstrate that
lowed clinically for 1.8 (1.6) years.
pregnancy and child outcomes following fetal ICH diagnosed on fetal
Neurodevelopmental outcome was
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MRI have a wider spectrum of outcomes than previously recognized.
Following fetal ICH, 75% of pregnancies result in live birth and 81%
of infants present with either normal
neurodevelopment or mild neurodevelopmental delays that require
physical and/or occupational therapy.
Fetal MRI description of ICH
location may aid in pregnancy outcome prediction and relates to postnatal neurodevelopmental outcomes.
A lower proportion of adverse pregnancy outcomes was seen with unilateral IVH, and this proportion
increased as the hemorrhage became
more extensive (from unilateral to
bilateral) and involved diferent areas
in the brain (from ventricles to parenchyma). The higher proportion of
normal neurodevelopment seen with
parenchymal ICH may be a result
of the lower sample size of survivors
seen with this hemorrhage. Our current fndings help to provide data on
fetal ICH and postnatal outcome that
can be used to improve counseling to
expectant mothers. Further studies
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should evaluate fetal ICH location,
size, and timing in relation to prognosis for specifc postnatal outcomes.
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Residual Gastric Volume Prior to Bedside Percutaneous
Endoscopic Gastrostomy Tube Placement: Do We Need to
Hold Tube Feeds Prior to Peg Tube Placement?

possibility is supported, in part, by
the decreased NPO time required
in infants and children, even though
their smaller stomachs and shorter
esophagi increase the possibility of
Co-Authors:
1
aspiration from a full stomach. Due
Tammy Ju, MD;
to this ambiguity, our study aims to
Lisbi Rivas, MD,
1
investigate if using an “on-call” NPO
CNSC; Jonathan
strategy that minimizes the length
Messing, NP;1 Kelsey Rosen, NP;1 and Babak
1
of holding tube feeds prior to PEG
Sarani, MD,
placement is safe by recording gastric
¹ The George Washington University School
residual volume (GRV) prior to PEG
of Medicine and Health Sciences
tube placement and assessing periprocedural outcomes. We hypothesize that there is less than 10ml
Percutaneous endoscopic gastrosGRV and no complications related
tomy (PEG) has been widely used
to leakage of gastric contents using
for the long-term feeding of patients
this strategy.
with a functional gastrointestinal
Here, we describe our experience
system that are otherwise unable to
using the “NPO on-call” strategy
intake solid or liquid food. There is
for holding tube feeds prior to PEG
currently no consensus regarding
tube placement for seventeen ICU
patients and describe
its safety. Continuous
Our “NPO on-call” strategy led to a median
tube feeds were held only
when the surgical team
time difference of 60 minutes between
was at the bedside and
ready to begin the prostopping tube feeds and insertion of the
cedure. A tracheostomy
was performed prior to
PEG. GRV and periendoscope for PEG.
procedura l outcomes
were recorded. Patient
the length of time that tube feeds
characteristics and results are sumshould be held prior to bedside PEG
marized in Table 1. The median time
tube placement in adult patients. The
from stopping tube feeds to insertion
traditional dictum of holding tube
of the endoscope was 60 minutes (30,
feeds (NPO) at midnight the night
115 IQR) and the median amount of
prior to PEG placement is not borne
GRV was 0 ml (0, 0 IQR). PEG was
out in the scientifc literature and may
successfully performed on all patients
put critically ill patients at risk of furand there were no post-procedure
ther malnutrition due to interrupted
complications such as peritonitis or
enteral tube feeding.1 However, it
aspiration.
is not known whether withholding
Enteral nutrition delivery is comtube feedings for a shorter time than
monly interrupted in ICU patients,
the current standard is safe. This
often due to airway management,
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digestive intolerance, and need for
diagnostic procedures. 2 Moreover,
ICU patients are already in a state
of elevated energy expenditure due
to the metabolic needs of the body
under stress and critical illness. 1
These factors together can lead to
large diferences between the caloric
needs of patients and the calories
actually delivered to them. 2 Low
caloric intake, especially in ICU
patients, can lead to an increased risk
of nosocomial bloodstream infections, hospital length of stay, and risk
of ventilator-associated pneumonia.3,4
Furthermore, caloric defcits in ICU
patients are associated with the
occurrence of sepsis, adult respiratory
distress syndrome, and renal failure.5
In order to reduce the occurrence of
these risks, interruptions in enteral
nutrition need to be minimized. This
understanding led to the adoption of
“NPO on-call” withholding of tube
feeding at GW to minimize the time
of interrupted feeding.
Our “NPO on-call” strategy led
to a median time difference of 60
minutes between stopping tube feeds
and insertion of the endoscope for
PEG. This is signifcantly less time
relative to the current standard practice of 8-16 hours. Given that these
seventeen patients also had a median
GRV of 0 ml and no PPD-1 complications, our fndings highlight that the
prolonged NPO time is not necessary
to performing endoscopy and PEG
placement safely.
In conclusion, our fndings indicate that minimizing time for which
tube feeds are held prior to PEG using
an “NPO on-call” strategy is a safe
practice and may prevent delay to
enteral nutrition.
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TABLE: Patient characteristics and results
BMI, body mass index; EGD, esophagogastroduodenoscopy; GRV, Gastric Residual Volume; LOS, length of stay; NPO, nulla per os; PEG,
percutaneous endoscopic gastrostomy; PPD-1, post-procedure day 1; TFR, tube feed rate;

Age

Sex

BMI

Hospital
LOS (days)

TFR
(mL/hr)

NPO-EGD
time
difference
(min)

60

M

26

25

50

10

0

Yes

None

73

F

28 6

18

40

719

0

Yes

None

83

F

23 5

11

42

100

0

Yes

None

45

F

21 5

12

54

155

0

Yes

None

52

M

35 9

15

130

60

200

Yes

None

71

M

51 1

14

54

30

0

Yes

None

59

F

31 7

19

50

10

0

Yes

None

62

F

27 2

28

58

20

0

Yes

None

76

M

32 3

8

40

525

0

Yes

None

62

M

33 1

14

42

11

0

Yes

None

94

F

19 9

16

54

98

5

Yes

None

57

F

24 3

11

50

210

0

Yes

None

31

M

24 5

5

30

115

5

Yes

None

77

M

34 5

8

58

80

0

Yes

None

62

F

27 2

25

58

50

0

Yes

None

74

M

36 7

15

29

44

0

Yes

None

79

F

28 7

15

45

45

0

Yes

None
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Association of Medication Mismanagement with Hospital-Related
Complications in Patients with Parkinson’s Disease
Christina Kallik,
MSII

TABLE 1: Comparison of baseline characteristics and outcome measures between PD
and non-PD patients

Co-Authors:
Melesilika Finau,
MSIV,1 and Andrew
Sparks, MS2
ADVISOR: Pritha Ghosh, MD1,2
1 The George Washington University (GW)
School of Medicine and Health Sciences
2 The GW Medical Faculty Associates

Parkinson’s disease (PD) is the second
most common neurodegenerative disease, afecting over six million people
worldwide.1 PD is defned by reduced
dopaminergic neurotransmission in
the basal ganglia causing motor symptoms of tremor, rigidity, bradykinesia,
and postural instability, as well as
non-motor symptoms ranging from
autonomic dysfunction to cognitive
decline. PD requires complex medication management to maintain the
delicate balance of striatal dopamine
to treat motor and non-motor symptoms. Maintaining this regimen is
challenging in the inpatient setting.
Medication errors involving mistimed
PD medications and use of contraindicated medications, such as neuroleptics or other dopamine-blocking
agents, are common in hospitalized
PD patients.2 Medication mistiming
has previously been shown to be
associated with longer lengths of stay
and more complications.3 However,
limited data exists examining the
relationship between use of contraindicated medications and hospital
outcomes in the PD population.
We aimed to investigate the incidence of medication mismanagement in hospitalized PD patients at
The George Washington University
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Variable

Control
patients
(n=1308)

PD patients
(n=377)

p-value

Female %

443 (33 9%)

120 (31 8%)

0 460

Age

74 7 ± 9 4

75 3 ± 9 7

0 315

Length of Stay, days,
median (Q1, Q3)

4 (2, 9)

10 (6, 20)

<0 001

30-day readmission

165 (12 6%)

96 (25 5%)

<0 001

Falls

24 (1 8%)

10 (2 7%)

0 320

Delirium

44 (3 4%)

24 (6 4%)

0 009

Hospital (GW Hospital) and explore
The most common reasons for admisthe potential relationship of medision were degenerative nervous system
cation mismanagement on lengths
disorder, septicemia, and urinary tract
of stay, 30-day readmission rates,
infection. Compared to controls, PD
falls, and delirium. We performed
patients had approximately doubled
a retrospective cha rt rev iew of
lengths of stay (p<0.001), 30-day
PD patients admitted to the GW
readmission rates (p<0.001), and
Hospital between January 2015 and
delirium incidences (p=0.009). No
January 2020. Lengths of stay, 30-day
diferences were observed between
readmission rates, falls, and
delirium incidences among
Our analysis suggests that medication
PD patients were compared
to age (±2 years), sex, and
mismanagement of PD patients at this
d ia g nosis-related g roup
( DRG)-matched non-PD
center is prevalent, and the use of concontrols. Subsequently, a
comprehensive chart review
was done to identify specifc
traindicated medications is associated
medication errors in the PD
cohort. Medication errors
with longer lengths of stay and higher
were grouped into 2 categories: mistimed administradelirium incidents.
tion of PD medications by
more than 30 minutes and
use of contraindicated medications.
PD and control cohorts regarding
Statistical analyses were performed to
falls (p=0.320) (Table 1). Medication
determine whether medication errors
mistiming occurred in 88.1% of PD
were associated with lengths of stay,
patients. 14% of PD patients were
30-day readmission rates, falls, and
prescribed a contraindicated medicadelirium.
tion, and those patients experienced
Three hundred seventy seven PD
significantly longer lengths of stay
patients were included in this study.
(p<0.001) and had signifcantly more
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delirium incidences (p=0.001). No statistically signifcant diferences were
observed in 30-day readmission rates
(p=0.248) or falls (p=0.408) (Table 2).
The most commonly used contraindicated medications were haloperidol
(38.18%), prochlorperazine (14.55%),
and metoclopramide (12.73%).
Our analysis suggests that medication mismanagement of PD patients
at this center is prevalent, and the
use of contraindicated medications
is associated with longer lengths of
stay and higher delirium incidents.
This supports several reports in
the literature regarding the frequency of medication mismanagement in hospitalized PD patients
and its potential impact.2-5 Further
analysis will need to be conducted
to specifically assess the impact of
medication mistiming on lengths of
stay, 30-day readmission rates, and
hospital complications, as this seems
to be a common occurrence. Notably,
our study could not assess whether
increased delirium incidences in
the PD cohort were a result of using
contraindicated medications or if contraindicated medications were used
to treat delirium. Nonetheless, this
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TABLE 2: Comparison of outcome measures in PD patients who did or did not receive
contraindicated medications
Outcome

No contraindicated
medications (n=339)

Contraindicated
medications (n=55)

p-value

Length of Stay, days,
median (Q1, Q3)

10 (5, 18)

16 (8, 28)

<0 001

30-day readmission

90 (26 5%)

10 (20 6%)

0 248

Falls

10 (2 9%)

-

0 408

Delirium

16 (4 7%)

10 (18 2%)

0 001

study represents an important step in
addressing the quality of care hospitalized PD patients receive and serves
as a starting point for creating and
implementing mitigation strategies
to improve the care of PD patients.
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Atopic Dermatitis is Associated with Multiple
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MSI
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Jonathan I
Silverberg, MD, PhD,
MPH1,2
1 The George Washington University School of
Medicine and Health Sciences, Department of
Dermatology
2 Northwestern University Feinberg School of
Medicine Department of Dermatology

Atopic dermatitis (AD) is a chronic,
infammatory skin disease associated
with intense itch, sleep disturbance,
psychosocial distress, and symptoms
of anxiety and depression.1 All of these
sequelae of AD may negatively impact
the emotional health and social functioning in children, and ultimately lead
to behavioral problems. We aimed to
understand the association between
AD and aberrant childhood behaviors.
Data were analyzed from the
Fragile Families and Child Wellbeing
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Study, a longitudinal birth cohort
study of 4898 children in 20 U.S.
cities.2 AD was associated with the
≥75th percentile of mean behavioral
scores at 5 years (multivariable logistic
regression; adjusted odds ratio [95%
confdence interval]: 1.51 [1.18-1.93]),
9 years (1.62 [1.32-1.99]) and 15 years
(1.44 [1.17-1.76]).
There was signifcantly increased
behavioral problems at age 15 when
AD persisted at ages 5, 9 and 15
(Poisson regression; adjusted risk
ratio [CI95]: 1.17 [1.01-1.35]), ages 5
and 15 (1.33 [1.08-1.63]) and ages 9
and 15 (crude risk ratio [CI95]: 1.27
[1.03-1.56]). AD was associated with
12 aberrant behaviors, particularly
fghting (repeated measures logistic
regression; adjusted odds ratio [CI95]:
1.40 [1.15-1.70]), physically attacking
people (1.38 [1.09-1.76]), being sullen
(1.31 [1.15-1.49]), worrying (1.41 [1.231.61]), and threatening others (1.35
[1.08-1.70]). AD at age 15 was associated with ≥ 75th percentile of the
Child Behavior Checklist (CBCL)

subscales: anxious/depressed (aOR
[CI95]: 1.44 [1.16-1.78]), withdrawn
(1.40 [1.11-1.77]), attention problems
(1.33 [1.09-1.63]), social problems (1.39
[1.13-1.72]) and aggressive (1.49 [1.221.82]). Significant two-way interactions were present between AD and
sleep as predictors of underactivity
(4.31 [3.06-6.08]), being threatening
(aOR [CI95]: 3.42 [2.20-5.34]), being
sullen (3.86 [2.74-5.43]) and nervousness (4.56 [3.29-6.32]).
Conclusion: Childhood AD, particularly persistent disease with sleep
disturbances, was associated with a
wide range of behavioral problems in
US children and/or adolescents.
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School of Medicine and Health Sciences,
Departments of Pediatrics and Neurology

Agenesis of the corpus callosum
(ACC), complete or partial, is one
of the most common brain malformations, occurring in 1:4000 live
births, and results in a wide spectrum
of clinical outcomes. 1 Fetal MRI
is increasingly utilized to discern
corpus callosum abnormalities that
are unable to be fully assessed with
ultrasonography. 2 This study aims
to describe the spectrum of fetal
brain abnormalities in ACC cases
diagnosed by fetal MRI,determine
the frequency of postnatal confrmation by brain MRI of fetal cases, and
understand pregnancy and postnatal
outcomes.
Methods: Patient medical records
from Children’s National Hospital’s
Cerner database from Jan. 1, 2012 to
June 30, 2019 with a referral for a possible brain abnormality (ACC, cavum
septum pellucidum abnormality, and/
or ventriculomegaly), prenatal neurological consultation, complete fetal
MRI, and confirmed ACC (partial
or complete type) on imaging were
included. Data on maternal medical
and obstetric history, prenatal testing,
prenatal imaging, labor and delivery,
neonatal birth history, and postnatal
evaluations/outcomes were recorded.
Cases were defned as isolated if ACC
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TABLE: Participant Characteristics
Mexican
n=10

Chinese/
Taiwanese
n=8

Total
n=18

Mean

38

34 4

36 4

≤30

2

3

5

31-40

2

4

6

>40

6

1

7

Naturalized

1

1

2

Permanent Resident

0

5

5

Work Permit

3

1

4

Overseas Born Citizen

0

1

1

Undocumented

6

0

6

Mean

20

11 9

16 4

LA

5

5

10

OC

5

3

8

10 (100%)

3 (37 5%)

13 (72 2%)

Age (years)

Legal Status

Time in US (years)
County

Undocumented family or friends

was the only brain fnding. Cases were
defned as complex if there were signifcant brain fndings in addition to
ACC: ventriculomegaly/hydrocephalus, posterior fossa malformation,
or malformation of cortical development. Each case was categorized as
partial or complete ACC and isolated
or complex ACC, and group comparisons on outcomes were analyzed.
Results: We evaluated 127 pregnant
women-fetal dyads by fetal MRI at
25.8 ± 5.3 weeks gestation. Forty-fve
(36%) had isolated-complete ACC,
17 (13%) had isolated-partial ACC, 46
(36%) had complex-complete ACC,
and 19 (15%) had complex-partial ACC
based on fetal MRI.
Pregna ncy outcome was live
bi r th i n 75, ter m i nation i n 36,

and intrauterine demise in three.
Seventy-one of 75 live births had
postnatal evaluations; 59 had postnatal
imaging (56 brain MRI; three head
ultrasound). In 40 of 59 (68%) cases,
postnatal imaging confirmed the
prenatal ACC fnding; 19 cases had differing prenatal and postnatal imaging
results. In them, 12 were identifed as
isolated-complete ACC prenatally and
were changed to complex-complete
(n=10) or isolated-partial (n=2) ACC
postnatally. Two cases were identifed
as complex-complete prenatally and
were changed to isolated-complete
ACC postnatally. Children with
partial or complete ACC had similar
rates of communication and/or motor
Continued on p. 78
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Continued fom p. 77
delays (44%); however, seizures were
more common in partial ACC cases
(26% vs. 17%). Complex ACC cases had
poorer outcomes than isolated ACC
cases, with complex cases having more
delivery complications (44% vs. 16%),
NICU admissions (69% vs. 28%), dysmorphisms in postnatal evaluations
(67% vs. 27%), hearing abnormalities
(20% vs. 5%), seizures (33% vs 11%), and
hydrocephalus (26% vs 0%).

Conclusions: Children with complex ACC demonstrate a poorer neurologic outcome compared to children
with isolated ACC. Fetal MRI can
help to differentiate isolated and
complex abnormalities of the corpus
callosum and is a useful tool to guide
prenatal counseling and postnatal
neurologic care.
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Increased Caspase-1 Activation in the Setting of COVID-19 Disease
Tina Vaziri, MSII
Healthy

Co-Authors:
Oral Alpan,1
and Matthew
Plassmeyer1

A

100
J!)_

ai
u
I-

80

+

60

~

ro

B

20

u
I0

()

d,
0
()

100

II****

~ 80

'7

8 60

3l-§.

~ E 40
~
0

20
0

Nigericin

0

•~

en
>ro ...J

()

-

•

+

■

•

+

Q) 40

0

en
ro
a. 20
en

■

ro

()

0

+

Nigericin

+

y,.e'5''1S'~
y,.e'5''1S'~
0~,o-'''1>
0~,o-'''1>

D

""**

■

~

+

'
'
~

+ >,

II

*""*

60

'5-'/S''l,o-'''1>
y,.e'5''1S'~
0~,cr'''1>
y,.e c,O~

C

II

...
...

80

~
0

+

****

'<I"

0

Nigericin

II

Q)

■

~
0

ICU

!!]_ 100

■

I

a.
en
()

78

-

■

non-ICU

II ****

4

Q)
en 40
ro

1 Amerimmune,
Fairfax VA
The latest threat to global health is
the ongoing outbreak of Coronavirus
Disease 2019 (COVID-19). Previous
studies have made it increasingly clear
that the innate immune system is a
critical player in a patient’s response
to COVID-19 infection. Further, the
disease-causing virus SARS-CoV-2
is a positive-sense RNA virus and
is therefore, speculated to be recognized by RNA-sensing pattern
recognition receptors of the innate
immune system. Finally, cytokine
levels of IL1-b and LDH are found to
be elevated in patients with COVID19, which are cytosolic proteins that
require release by infammasome activation and membrane rupture, respectively.1 In this study, our lab shows
that excessive caspase-1 inflammasome activation contributes to infammation in the setting of COVID-19.
Blood samples were obtained
from patients that tested positive for
COVID-19 by RT-PCR as well as
samples from COVID-19 negative,
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FIGURE 1: Caspase-1 expression as % positive and mena fuorescence intensity
(MFI) in CD3-negative (B+NK cells) CD3+ and CD3+CD4+ cells COVID-19 patients
show increased expression both at baseline as well as after nigericin stimulation with
p< 0001
healthy controls. Peripheral blood
mononuclear cells (PBMCs) were
isolated from whole blood using a
ficoll gradient and centrifugation,

and subsequently stained with a
mix of fuorescent-conjugated antibodies. A FAM-FLICA Caspase-1
and 3/7 Assay Kit was used to assess
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caspase expression by flow cytometry. Samples were run on the Canto
Cytometer and files were analyzed
using FCS Express software.
Our experiments found that caspase-1 expression was elevated in
COVID-19 patients compared to
healthy controls, with highest levels
seen in ICU patients compared to nonICU patients (Figure 1). In order to
show that there is distinct elevation in
the pyroptotic pathway without elevation in the other caspases involved in
the programmed apoptotic pathway,
we also looked at caspase-3 and caspase-7 expression in isolated PBMCs.
Indeed, there was no statistical diference in expression of these proteins
between COVID-19 patients and
healthy controls (Figure 2).
O u r f i nd i n g s i nd icate t h at
COVID-19 patients may have excessive activation of pyroptosis through
the caspase-1 infammasome. Future
experiments aim to better understand the consequence of this aberrant inf lammasome activation on
the immune system and possibly
on red blood cell function. Our lab
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FIGURE 2: Caspase-3/7 expression as % positive in CD3+CD8+ and CD3+CD4+
cells COVID-19 patients show no signifcant difference in expression of caspase 3/7,
which are mediators of apoptosis
has performed in vitro experiments
on whole blood using a pan-caspase
inhibitor to show that capase-1 levels
can successfully be attenuated and
hopes to explore this drug in a phase
I clinical trial for the treatment of
patients with COVID-19.
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An Anatomical Study of the Foramen of Monro: Implications in
Management of Pineal Tumors Presenting with Hydrocephalus
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For pineal tumors presenting with
hydrocephalus, simultaneous endoscopic third ventriculostomy (ETV)
and tumor biopsy is commonly used
as the initial step in management.1, 2,
4, 5
To analyze the restriction which
the foramen of Monro poses to this
procedure, one must start with a
detailed description of the microsurgical anatomy of the foramen in living
subjects. However, the orientation
and shape of the foramen of Monro
make this description difcult with
conventional imaging techniques.3, 5
Method: Virtual reality technology was applied to MRIs of 30
living subjects without hydrocephalus, as well as to MRIs of 16 patients
with hydrocephalus, to generate
precise anatomica l models with
sub-millimeter accuracy. The morphometry of the foramen of Monro
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FIGURE 1: Measuring the dimensions of the Foramen of Monro In this example, the
short axis is measured (a) To start the measurement, a preliminary ruler was implanted
using the top-down view on the foramen Inset—orientation view of the top-down view
along the axis of the foramen This ruler was then examined for placement and accuracy
in multiple angles in 3D space, with the ventricle and foramen frst as empty spaces and
then as a solid “cast” (b and c) Every foramen was measured in this fashion and data
recorded only when confrmation of the correct and precise placement of the ruler was
obtained (d)
was studied in each group. In addition, displacement of the margins of
the foramen was studied in detail for
simultaneous ETV and pineal tumor
biopsy through a single burr hole.
Results: In 30 normal subjects, the
foramen of Monro had oval-shaped
openings averaging 5.23 mm2. The
foramen was larger in people above
age 55 (average 7.19mm2 over 55,
versus 3.28 mm2 under 55, p = 0.007)
and larger on the left side compared
to the right in 73% of study subjects
(average 5.93 mm2 left, versus 4.52
mm2 right, p = 0.002). For 16 patients

with clinical presentation of hydrocephalus, the average opening was
32.6 mm2. Simulated single burr
hole simultaneous ETV and pineal
tumor biopsy was performed in 10
specimens. Average displacement of
the posterior and anterior margins of
the foramen was 5.71 mm and 5.76 mm,
respectively. However, maximum displacement reached 9.3 mm posteriorly
and 10 mm anteriorly.
Conclusions: T he fora men of
Monro is an oval-shaped cylinder that
changes in size and orientation in the
hydrocephalic patient. If universally
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applied to all patients regardless of
foramen and tumor size, ETV/biopsy
can displace structures around the
Foramen of Monro up to 1 cm, which
can potentially lead to neurological
damage. Careful pre-operative assessment is critical to determine if a single
burr hole approach is safe.
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FIGURE 2: Generating the trajectories and measuring the displacement of the
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Foramen of Monro Ideal trajectories extended from the pineal tumor and tuber cinereum
(a), through the center of the foramen of Monro (b), to the surface (c) The study entry (SE)
was then calculated by fnding the midpoint of the exits points of the ideal trajectories
(c) Biopsy (blue) and ETV (green) trajectories were then projected from the SE back to
the targets (d) Examining the foramen of Monro with these trajectories in close-up, the
anterior displacement (X) and posterior displacement (Y) were measured (e)
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